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ABSTRACT 
 
Immunisation is the most cost-effective public health intervention currently available. 
However, immunisation raises ethical conflicts as it may be considered a public good 
with little individual benefits. Considering the effectiveness of immunisation in controlling 
vaccine preventable infections and the constant threat of outbreaks from conditions like 
measles, refusal to participate in a universal immunisation programme is morally 
questionable. This research analyses the ethical issues brought up by universal 
immunisation in South Africa. It focuses on local practice and on selected risk benefit 
issues.  
 
The research method used is literature search with analysis in the form of critical 
thinking and moral reasoning. The findings are that universal immunisation is ethically 
defensible based on various ethical theories and principles. South Africa’s experience 
with the 2003 -2005 measles outbreak points to a social contract for individuals to 
immunise their children. The argument of taking personal risk for public good and the no 
additional benefit argument once herd immunity is reached (presented by Dawson), are 
refuted. Risk-benefit elements for each infectious condition and vaccine are continually 
changing. This demands an ongoing assessment of risk-benefit issues for each vaccine 
and targeted infections to ensure the use of vaccines with optimal safety levels that are 
appropriate in South Africa.  
 
Recommendations are made on immunisation policy and legislation aimed at improving 
ethical practices of the immunisation service. Implementation of the recommendations 
will help ensure an immunisation programme that is proactive in addressing associated 
risks and should help eliminate litigation. The main recommendation of a legislated 
Compensation System for those who suffer severe adverse events following 
immunisation is directed at just distribution of benefits and burdens.  
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 Nomenclature  
AFP Acute  Flaccid Paralysis 
AEFI Adverse Event Following Immunisation 
BCG Bacillus Calmette - Guerin 
CDC Centre for Disease Control and Prevention 
DT Diphtheria and Tetanus 
DPT -Hib Diphtheria Pertussis and Tetanus - Haemophilus  
Influenzae type b 
EPI Expanded Programme on Immunisation 
EPI - SA Expanded Programme on Immunisation in South Africa 
IPV Inactivated Polio Vaccine 
MCC Medicine Control Council 
NCL National Control Laboratory 
     NDEMC     National Adverse Drug Event Monitoring Centre  
NDOH National Department of Health 
OPV Oral Polio Vaccine 
PEI Polio Eradication Initiative 
PHC Primary Health Care 
SA South Africa 
SIAs Supplementary Immunisation Activities 
UK United Kingdom 
UNICEF United Nations Children’s Educational Fund 
USA  United States of America 
VAPP Vaccine Associated Paralytic Polio 
VcDPV Circulating Vaccine Derived Poliovirus 
VPDs Vaccine Preventable Diseases 
      WHA World Health Assembly 
WHO World Health Organisation 
WPV Wild Poliovirus 
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1.  Introduction and Literature Review 
Immunisation is one of the most cost-effective public health interventions. Consequently 
it has been appropriately referred to as one of the greatest public health achievements 
of the twentieth century (CDC 1999: 243-248). The World Health Organisation estimates 
that immunisation saves over two million lives per year (WHO 2005: 288), and has the 
potential to save even more. The gains made by immunisation include amongst others: 
smallpox eradication, the significant decline in measles cases and the pending polio 
eradication.  The benefits of immunisation extend beyond the control and elimination of 
infectious diseases; immunisation can help control antibiotic resistance and has resulted 
in a reduced incidence of hepatocellular carcinoma (Andre 2003:593-595). Furthermore, 
immunisation programmes have helped to improve the primary health care infrastructure 
in developing countries. There is an understanding that a properly implemented 
immunisation programme will have positive impact on economic growth; particularly in 
developing countries through improvement in survival as good health forms the basis for 
economic growth (Bloom 2005:15-39). The broad value of immunisation and its 
economic impact has been acknowledged; the 1993 World Development Report, 
“Investing in Health“, listed immunisation as the first component of an essential public 
health package (World Bank 1993 cited in Bloom 2005).  It is evident that immunisation 
does not just benefit the present generation; its benefits will continue to be reaped by 
many more generations to come. 
 
The immunisation programme, similar to other public health programmes is in keeping 
with the consequence based theory of utilitarianism, which pursues the principle of 
“greatest good for the great number”. Utilitarianism plays a significant role in the 
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development of public policy based on its focus on utility (Beauchamp 1994: 55). 
Utilitarianism provides for an objective assessment of everyone’s interest and aims to 
maximise benefits.   This is true for immunisation, as it aims for individual protection and 
public good. Furthermore immunisation encompasses the principles of beneficence and 
justice because it promotes health and welfare of individuals and the public, based on a 
collective effort. 
 
Despite the unquestionable benefits of the immunisation programme worldwide, the 
acceptance of universal immunisation in developed countries has been a challenge. A 
number of vaccine preventable infections are no longer perceived by many to pose 
significant risk to individuals. Many adults living in developed countries and even some 
of their doctors graduating from medical school have not witnessed the misery that can 
be caused by vaccine preventable infections (Vernon 2003: 399-404; Obaro 2003: 1423-
1431). Immunisation has come to face the failures of its own success. The very 
programme that led to eradication and virtual elimination of conditions that in the past 
caused a lot of human suffering and were a significant public health threat is now 
perceived to pose more risk from the side effects of the vaccines than the risk from the 
diseases it is meant to prevent. There may be a danger that communities in developed 
countries will soon forget the benefits of vaccines, including the ones which are still not 
available in the developing countries. There may be a tendency to dwell in the trivial, self 
limiting adverse effects of vaccination (Vernon 2003: 399-404).    
 
Opposition to universal immunisation presents from many fronts: the anti vaccination 
movements; alternative health care practitioners and their clients; the World Wide Web 
contains numerous anti vaccination articles; religious groups and other individuals 
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opposed to immunisation. Freed (1996), indicates that the media plays a big role in 
creating a harsh climate for immunisation services and raises concerns on vaccine 
safety that cannot be underestimated. The information published by the media can have 
far reaching consequences; yet this information is often biased, distorted and lacks 
scientific facts (Freed 1996:1869-1872). Furthermore, published information may be 
biased towards reporting more on vaccine risks than on benefits. Certain medical 
controversies and lack of agreement in the medical community on the side effects and 
risk posed by vaccines have further fuelled opposition to immunisation, caused fear and 
uncertainty amongst parents and care givers. The controversy around Measles Mumps 
Rubella (MMR) vaccine and the unproven allegations that this vaccine is associated with 
autism is one good example (Salmon 2006:436-442; Clements 2003:22-26).   
 
Parents base their decisions on information available to them, even though it may have 
no scientific basis and may be misrepresented facts. An individual when weighing the 
benefits and the risks may end up opting not to immunise her child based on available 
information. There is no doubt that as long as the relevant organisms have not been 
eradicated, as more and more individuals choose to do what they believe is in their best 
interest and do not immunise their children, the immunisation coverage drops. With time 
re-emergence and outbreaks of previously controlled infections occur. Examples of re-
emerging diseases related to a drop in immunisation coverage include outbreaks of 
pertussis and measles in the United States and United Kingdom, outbreaks of diphtheria 
in Russia (Salmon 2006: 436-442; Isaacs 2004: 392-396 & Bradley 1999: 330-334).  It is 
evident that those who oppose universal immunisation, claiming that there is more risk 
from vaccines than from the diseases targeted may be misleading the parents and the 
public. It is doubtful that anyone who does this may be bold and honest enough to stand 
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up and acknowledge misleading the people when outbreaks occur (Clements 2003: 22-
6). Based on the benefits of immunisation and the challenges mainly developed 
countries face in increasing immunisation coverage, immunisation services are 
compulsory in some developed countries.   
 
The intrinsic factors of a universal immunisation programme form the basis of moral 
conflicts. Immunisation protects individuals, and when large enough numbers are 
immunised, a high level of population (herd) immunity is reached and public protection 
results. This brings up the conflict of individual rights and actions versus public good. Of 
essence to consider, notwithstanding individual rights, is that governments have a 
special interest in ensuring high immunisation coverage, due to its benefit of protecting 
the entire population.  
 
Based on these qualities of an immunisation programme and the issues indicated 
earlier, refusal to participate in a universal immunisation programme (compulsory or 
voluntary), is morally questionable. The moral conflicts brought up by refusal of 
immunisation need to be addressed. To address the major aspect of this conflict, this 
research aims to: establish the moral basis of universal immunisation services in relation 
to ethical approaches, conduct an ethical analysis of the key arguments entailed in 
immunisation refusal, reflect on immunisation policy in South Africa, interrogate selected 
risk benefit issues and finally draw up recommendations for the immunisation services in 
South Africa.  
 
There is a significant amount of literature on ethics and immunisation, however none 
has conducted a comprehensive ethical analysis with specific focus on a developing 
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country like South Africa, which is the object of this study. Paul and Dawson (2005: 393-
406) consider ethical issues that relate to the polio eradication programme in India. This 
work concentrates mainly on risk and benefits of the mass polio immunisation strategy 
as part of the global polio eradication effort and the risk of developing vaccine 
associated paralytic polio (VAPP). They also look at the issue of informed consent and 
disclosure on the risk associated with immunisation. Although, this work covers some 
important aspects which are of relevance to this research, the main focus was polio 
mass immunisation, its risk and associated ethical issues in India. 
 
Dawson (2004) on “Vaccination and the Prevention Problem” critically reviews the 
objection to preventive medicine, using preventive vaccination. He brings up important 
concepts which are of relevance to this study. He maintains that, herd protection an 
important public good which is a benefit shared by individuals in society, should be 
acknowledged by individuals. He disputes the argument based on supposed inequities 
in risk. Dawson’s main focus is on comparing therapeutic vaccination and preventative 
vaccination.    
 
The work of May and Silverman (2005:12-15) has concentrated on some aspects of 
group refusal of immunisation. This work looked at the legal limitation of government 
authority in relation to exemption from immunisation. Due to the fact that certain groups 
are more likely to appeal for exemption, this may have the undesirable effect of loss 
herd protection amongst that particular group, which may lead to disease outbreaks. 
May and Silverman’s work considers the complication that “government authority cannot 
single out specific groups to bear an infringement on liberty or to bear a burden”. In this 
case government has limitations in disallowing exemptions from immunisation in such 
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groups, particularly religious groups which have long been recognised as a protected 
characteristic. Whilst this work covers group refusal, it concentrates on the legal aspect 
of addressing this problem and the limitations faced by government authority. It does not 
focus on the ethical basis for group refusal and the implications thereof. 
 
There is significant amount of literature on the justification for or the need for compulsory 
immunisation services in the United Sates of America and in the United Kingdom (Isaacs 
2004: 392-396 and Bradley 1999: 330-334). Isaacs’ work has relevance to this research, 
it considers the ethical basis for immunisation, looking at communitarian, 
consequentialism and the right based approaches; the risk benefit issues; herd immunity 
and the free riders. Their work has more focus on establishing the justification for 
compulsory services. Bradley’s work is also on the need for compulsory immunisation in 
the United Kingdom. The focus is on a right based approach; right of parents to raise 
children according to their own standard, the right of children to receive health care and 
protection and the right of communities to be protected from vaccine preventable 
infectious diseases. Bradley’s work does not cover the ethical basis of a universal 
immunisation programme. This research is an in-depth analysis of ethical issues, 
considers the local setting and specific country experience.  
 
This research report is divided into eight (8) chapters. The first two chapters are the 
introduction and methodology.  Chapters 3 to 7, form the main body of the report. 
Chapter three deals with immunisation as a public health programme. It outlines the 
different orientation of early bioethics and public health. It then looks at immunisation 
programme as a global intervention programme, prioritised in many countries. The 
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nature of the programme as it requires public cooperation and the principles for making 
immunisation universal are covered.  
 
Chapter four (4) looks at the ethical approaches that can be considered to form the 
basis for a universal immunisation programme and those that may be opposed to 
immunisation. The major ethical approaches in relation to universal immunisation are 
considered. The ethical approaches referred to are: Utilitarian, Kantianism, Casuistry, 
Communism and Liberty. The reasoning of early philosopher, John Stuart Mill and his 
“harm/harm to others principle” is reviewed in relation to universal immunisation. The 
ethical principles are also briefly considered.  
 
Chapter five (5) considers the argument that immunisation is aimed at public good whilst 
individuals take personal risk. This is considered in depth based on Dawson’s 
(2004:515-530) argument, the prevention problem. The other argument by Dawson 
(2007:160-178) that once herd immunity is reached there is no additional benefit to 
society in individuals being vaccinated, therefore there is no moral obligation for 
individuals to subject themselves to immunisation, is refuted. This chapter considers 
closely the concept of the social contract as suggested by Freed (1996: 1869-1872). 
The concept of a social contract for all members of society to immunise their children is 
upheld, based on the obligation of individuals to contribute to society for the protection 
enjoyed by all.   
 
Chapter six (6) considers briefly the area of group refusal. The factors which contribute 
to group refusal and the consequences are covered. Specific reference is made to the 
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suspension of polio immunisation activities in the Northern States of Nigeria from 2003 
to 2004, and the consequences thereof.  
 
Chapter seven (7) looks at specific ethical issues which relate to the expanded 
programme on immunisation in South Africa. The immunisation policy; the constraints 
faced at service delivery, adverse events following immunisation (AEFI) and the risk 
benefit issues as they relate to whole cell pertussis and oral polio vaccine are 
considered. This chapter deals with the need to closely monitor AEFI and to continually 
review the national immunisation policy as the epidemiology of the diseases targeted 
changes and newer, safer vaccine products become available.  
 
Chapter eight (8) covers the recommendations and conclusion of the main findings of 
this research.  Having conducted an ethical analysis of the conflicts raised and 
considered risk–benefit issues, the essay concludes with a set of concrete 
recommendations on revision of policy and legislation. The thesis of this research is that 
the recommendations will allow these instruments to respond appropriately to the ethical 
issues identified and will position the immunisation programme to respond to ethical and 
legal challenges faced to the benefit of society at large.   
 
 In most sections issues are presented in a generalised way as they apply to most 
immunisation settings; however the focus is on South Africa. 1 The terms immunisation 
and vaccination are used interchangeably. It is acknowledged that some may question 
such use. The understanding is that most have become accustomed to the use of the 
                                                 
1 The focus of this research is on universal immunisation services offered through the Expanded 
Programme on Immunisation in South Africa (EPI-SA). 
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term immunisation where strictly speaking vaccination should have been used. Similarly, 
the terms herd protection and herd immunity will be used interchangeably.   
The arguments used in this research are based on immunisation for contagious vaccine 
preventable infections (VPDs) like diphtheria, polio and measles, where the concept of 
herd immunity applies.2 The immunisation: of adults, workers as part of health and 
safety programmes and immunisation in response to threats of bioterrorism are not the 
focus of this research. There is no specific focus on mass immunisation campaigns.  
 
                                                 
2 Whilst immunisation for conditions like tetanus is recommended, a high level of immunisation coverage 
for such conditions has no effect of herd immunity, as vaccination protects only individuals and their 
unborn offspring in the case of tetanus. 
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2.  Methodology and Data Analysis 
Methodology 
The method used in this study is literature search and ethical analysis of the issues 
raised in line with the objectives and included:  
• Literature search and review, using appropriate key words 
• The use of the World Wide Web to access and get references to relevant 
publications. Search engines used: PubMed / Medline, Google Scholar, Lexis 
Nexis and ProQuest 
• Reflecting on material from scientific and academic textbooks; ethics, medical 
and medico-legal journal articles published on the topic of immunisation,  ethics 
and public health 
• Reflecting on current practices and policy of the immunisation programme in 
South Africa 
• Analysing the ethical issues raised from these sources regarding immunisation 
services. 
 
Data Analysis  
Data was analysed in the form of critical thinking and moral reasoning on the main 
scientific and ethical issues involved in universal immunisation: public good versus 
individual rights, refusal of immunisation, the risk–benefit issues and experiences of the 
immunisation programme in South Africa in relation to measles outbreak. Reference is 
continuously made to the ethical and medico-legal articles sourced. 
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3.  Immunisation as a Public Health Programme 
3.1 Public Health and Bioethics: The Different Orientation 
The early history of Bioethics is represented by two divergent approaches. The first is 
the Potter model. Van Rensselaer Potter, an oncologist working in the USA state of 
Wisconsin, first coined the term “bioethics”. He used it to mean “life-ethics” and applied it 
to the practice of medicine within the scope long-range environmental concerns (Potter 
1975: 299).3  
At about the same time (± 1971), the Georgetown bioethics model emerged. This view 
looked at concrete medical dilemmas. The focus was on the “rights and duties of 
patients & healthcare professionals, rights & duties of research subjects & researchers, 
and the formulation of public policy guidelines for clinical care & biomedical research” 
(Reich 1994: 322-323).  The Georgetown model was politically backed and became the 
predominant model for biomedical ethics in the USA and in many other countries. It was 
supported by Beauchamp and Childress’ Principlist approach to Bioethics. The 
application of such principles became what is called the “Georgetown mantra”.4  
Subsequently, application of the principles in medical practice involved mainly 
preserving the good of an individual, autonomy, and individual rights (Bayer 2004: 473-
492; Callahan 2002: 169-196; Kass 2001: 1776-1782). It should be noted here that there 
has been a concerted movement, mainly because of environmental concerns to “reunite 
the bioethical twins [the Potter and Georgetown models] that have been separated since 
birth” (Reich 1995: 31).  
                                                 
3  Potter postulated links between adverse environmental effects and cancer; his concern was that a new 
ethics, a bio (life) ethic was needed for the survival of the human species.  
4 Beauchamp and Childress’ four principles of bioethics are: autonomy, non-maleficence, beneficence, 
and justice.  
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Currently, bioethics as a field is constantly re-defining itself reconsidering its orientation, 
attempting to stimulate perceptions of which things count, to clarify implications of 
excluding some issues and voices, and to illuminate the intellectual and moral culture 
that continues to shape it.    
 
Public Health programmes, including immunisation raise a number of moral conflicts that 
are not adequately addressed by the initial focus of bioethics and thus require their own 
ethical appraisal (Callahan 2002: 169-196). The field of public health raises distinct 
questions, moral and legal conflicts which are in sharp contrast to the earlier focus of 
bioethics. The orientation of public health programmes is public good and societal 
benefit. Individual good, the focus of clinical medicine cannot determine the course of 
action in public health interventions. Coughlin (2006), Bayer (2004) and Callahan (2002) 
point out that, public health programmes (including the immunisation programme), are 
by their nature: paternalistic, utilitarian, communitarian and consequently put limits on 
individual rights.  
 
The deep divide between the central commitment of earlier bioethics and the practice of 
public health has been acknowledged. Bayer (2004) has questioned the relevance of 
autonomy focussed bioethics in the role of public health and concludes:  
 “May be bioethics cannot serve as a basis for thinking about balances required in the 
defence of public health…As we commence on the process of shaping an ethics of public 
health, it is clear that bioethics is a wrong place to start”.  
 
Whilst this research acknowledges the ethical conflicts brought about by public health 
practice, it refutes this conclusion. Bioethics offers a broad background to guide 
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decisions and practices. It is an unfortunate consequence that the greatly ‘marketed’ 
Georgetown model of bioethics (the four principles) was considered as the only way to 
look at ethical problems, while their foundations were less-highlighted.5  For example, 
the focus on individualism and autonomy should be considered in the context of the 
USA where autonomy is a greatly emphasised cultural libertarian value.  This concept, 
as numerous multi-cultural authors have emphasised, is often tempered by one’s 
particular cultural background.6  Moreover, it expresses the need for the roots of 
autonomy to be placed back in its original focus: that of respect for persons. Bioethics 
can indeed help address the dilemmas faced in public health practice as long as we do 
not equate public health ethics to clinical bioethics.  Callahan (2002) and Kass (2001: 
1776-1782) hold a similar view and suggest that instead of a focus on conflicts in 
bioethics and public health we should look at issues with a level of maturity to the benefit 
of both public health and bioethics.  
An important difference in approaches is that of prevention versus treatment. Policy 
makers have a responsibility to implement public health interventions, as these provide 
high returns for a large number, are cost-effective and are mainly preventative in nature. 
Policy makers should therefore prioritise interventions that prevent the onset diseases, 
that is primary prevention measures. Primary prevention programmes like immunisation 
are much more desirable for the health of populations and individuals in comparison to 
secondary prevention measures, which merely limit disease progression.   
 
                                                 
5 The four principles have their roots in a combination of deontology, utilitarianism and the works of W. 
D. Ross (Beauchamp and Childress 1994).  
6 See for example: Asai, A and Sakamoto, S. 2007. Self-determination of death in Japan: A review and 
discussion. Eubios Journal of Asian and International Bioethics, 17 (2): 35-40; Carlisle, S. and Hanlon, P. 
2007. The complex territory of well-being: contestable evidence, contentious theories and speculative 
conclusions. Journal of Public Health, 6 (4). 
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It is the very nature of preventative public health programmes that brings about the 
ethical and legal conflicts, most of which are in sharp contrast to principlism. The main 
differences between public health and clinical medicine are that: the initiative for public 
health programmes comes from public health professionals and or government 
agencies, public health programmes are directed at public good and the pervasiveness 
of public health programmes which may interfere with individual lives (Dawson 2007:  
2-3 ; Blum 2006: 273-281).  These features are in sharp contrast to e.g. clinical medicine 
where an individual seeks healthcare (often from a single individual) due to an illness. 
Participants in a prevention programme are contrary to this as they are healthy or 
asymptomatic individuals. This creates a prerequisite for public health programmes to be 
vigilant on safety, as the level of risk tolerance becomes low. The pervasiveness of the 
programmes and public orientation creates the conflict of individual good versus public 
good. The question arises as to when can a public health intervention be enforced, 
putting limits on individual freedom?    
 
However, public health is not aimed at violating or overriding individual rights, rather it is 
in a particularly challenging situation where the health of the public has to be protected 
while respecting individual rights and autonomy. This should be viewed as the main 
focus of public health ethics, which is referred to as a “dual responsibility” that must 
involve an interplay of protecting the welfare of individuals whilst maintaining the primary 
goal in public health, that of public welfare (Coughlin 2006).  
 
This tension is a core feature of public health ethics.  Suggestions as to the alleviation of 
such have been proposed by writers such as Gostin et al. (2003) who suggest that 
coercive measures which violate individual human rights are only acceptable when the 
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risk to the public’s health is demonstrable, the intervention is likely to be effective and 
cost-effective, when it is not overly invasive, when it is distributed fairly amongst the 
population, and that the process for pursuing the intrusive intervention is legally just and 
publicly transparent. So, public health ethics in practice does recognise the links 
between human rights, community, as well as individual health (Mann 1996: 924-925); 
so to say that public health ethics ignores these important considerations is perhaps an 
oversimplification of the nature of public health ethics (Wynia 2005:6-8).   
3.2  Immunisation as a Global Priority Intervention Strategy  
Immunisation is a global public health intervention strategy. The World Health 
Organization (WHO) launched the Expanded Programme on Immunisation (EPI) in 
1974, from which time additional antigens were added on the immunisation programme. 
Recognising the enormous benefits of immunisation, the United Nations (UN) and many 
countries consider the Expanded Programme on Immunisation as a priority programme. 
In keeping with this priority rating, UN agencies: WHO and UNICEF have a specific 
mandate to provide support and ensure effective immunisation programmes in 
developing and poorer countries of the world.  
 
Furthermore, the UN Special Sessions and the World Health Assembly (WHA) have 
over the years adopted a number of resolutions on the control of vaccine preventable 
diseases.  These include resolutions on: wild poliovirus eradication, measles control and 
the more recent resolution on the Global Immunisation Vision and Strategy (GIVS). 
GIVS was endorsed by the World Health Assembly in 2005 (WHA 2005); it aims for the 
control of vaccine preventable diseases through increasing global access to 
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immunisation services. UN member states have a mandate to implement these binding 
resolutions and ensure effective immunisation programmes in their countries.   
 
3.3 The Need for Public Cooperation 
The effectiveness of an immunisation programme and its ability to achieve control of 
infectious diseases demands that a large number of susceptible individuals be 
immunised. When a large majority of people in a community are immunised, disease 
transmission is interrupted and the risk of disease is significantly reduced. When such a 
level of population immunity is reached it is referred to as herd immunity with resultant 
herd protection. At this stage, individuals receive protection irrespective of whether they 
have contributed to this collective effort or not (Isaacs 2004). Consequently the 
incidence of the disease drops and individuals are less inclined to take the minimal risk 
of immunisation when they can be protected by herd immunity and the risk of the 
disease appears to be remote. This creates the  “Tragedy of the Commons”. Malone et 
al draws a striking analogy with that of a community arrangement for cattle to graze in a 
common pasture. Individuals keep on adding more of their own cattle to reap individual 
benefits, this eventually leads to overgrazing and defeats the community interest of 
maximising food production (Hardin 1965, cited in Malone 2003: 262-284). Similarly in 
the case of immunisation, as more and more individuals refuse to immunise their 
children, the level of population immunity drops, this eventually results in outbreaks and 
re-emergence of previously controlled infections. 7  
  
                                                 
7  This position is supported by others. See e.g. Blum, 2006; Salmon, 2004; and Bradley, 1999. 
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Public health now emphasises greater community empowerment and its greater 
participation, so in many respects the field has become more interdisciplinary and 
complex.  It is evident that for an immunisation programme to be effective, public 
cooperation is required. A factor which may hinder community understanding of a 
vaccination programme is that contemporary community members (particularly parents) 
have never lived through an epidemic such as measles. This tends to diminish the 
perception of the need for vaccination while at the same time, the same parents may 
have heard about errors in medical interventions; this is referred to as the problem of 
‘misconceived risk’ (May 2003). Media portrayals which exaggerate or trivialise the 
benefits and burdens of vaccination programmes can greatly effect public perceptions.  
So, public health personnel must consider media communication as an important factor 
in public health and community interactions. This is of particular importance when 
considering childhood immunisation programmes.  
 
Immunisation refusals pose a significant problem for the programme and the control of 
vaccine preventable diseases (VPDs). Unvaccinated children put those who cannot be 
vaccinated for medical or other reasons at risk. A higher incidence of VPDs and 
outbreaks among communities with high level of exemptions in the USA is well 
documented (Salmon 2006: 436-442; Feikin 2000: 3145-3150). It is reported that the 
last significant polio outbreak in the USA was amongst communities religiously 
exempted from mandatory immunisation (Salmon 2001:  289-295).  
 
Another case of misconceived risk which resulted in refusal to immunise occurred in 
Japan with tragic results. Following media coverage concerning neurological injuries 
suffered by two children allegedly caused by the DPT vaccine, the public responded with 
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a refusal to comply with immunisation for pertussis which was a public health mandate. 
Due to parental refusal, the coverage supplied by immunisation dropped drastically from 
1974 to 1976.  A pertussis epidemic occurred in 1997 that resulted in an excess of 13, 
000 cases, and 41 deaths (Gangarosa 1998).  
 
With the need for public cooperation to make an immunisation programme successful, 
the role of public education including that of the media cannot be overemphasised. It is 
essential that strategies be developed for clear, informative and non-sensationalised 
reporting of public health issues. This requires the cooperation on the part of both the 
media and the public heath officials.  According to Schuchman and Wilkes (1997: 976), 
media sensationalism comes about by both scientists and reporters failing to appreciate 
each other’s rules of communication resulting in blaming each other for misleading the 
public. To have an immunisation programme succeed, public health officials must 
ensure the cooperation of the public. To this end, recognition of a community’s cultural, 
experiential, social, and economic circumstances and the ways in which public health 
messages are conveyed become paramount factors the ways public cooperation is 
elicited.    
 
3.4  Principles for making immunisation universal 
The decision for making immunisation services universal follows special guidelines 
which are grounded in the field of public health. These guidelines entail beneficence, 
non-maleficence and justice principles. WHO has developed a decision making 
framework which guides decision making and spells out the important considerations 
before a new vaccine can be introduced into a universal immunisation programme 
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(WHO 2005). This guide follows a similar framework of ethics for public health and for 
implementing public health interventions, proposed by Kass (2001:1776-1782). Kass 
proposed a 6 step framework for ethical analysis of an intended public health program, 
which covers: 1) the public health goals, 2) effectiveness in achieving the set goals, 3) 
known and potential burdens, 4) alternative approaches, 5) fair implementation and 6) 
equitable balancing of burdens and benefits. In this framework, there is an emphasis on 
fair implementation and ensuring that a programme seeks to minimise societal inequities 
and at the very least does not exacerbate existing inequities.  
 
This ethics framework for public health is quite similar to the WHO decision making 
framework for decision making in introducing new vaccines for universal immunisation. 
According to the WHO framework for universal immunisation there are two major areas 
to consider: the policy issues and programme issues (WHO 2005). Programme issues 
although important in assessing the practicality of implementation, are not considered 
any further in this research. Policy issues are of primary importance and include: 
disease burden, effectiveness of the intervention, safety of the intervention (vaccine), 
cost-effectiveness of the vaccine and net impact on the immunisation programme as 
well as the health sector. Considering the disease burden informs on the assessment of 
a disease as a public health problem. Included in this analysis is: disease incidence, 
hospitalisation, mortality and complications. Cost-effectiveness and fiscal impact is a 
significant area, which is assessed in relation to the many competing health needs. This 
determines whether a country will be able to afford the intervention. Vaccine safety and 
effectiveness are addressed in clinical trials and assessed by the National Regulating 
Authorities (NRA) during licensure. Vaccines have to meet stringent international and 
local requirements on safety and effectiveness before licensure.  
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Verweij and Dawson (2004:3122-3126) have suggested a set of ethical principles to 
guide universal immunisation programmes, based on discussions amongst experts in 
public health and ethics. The principles suggested by Verweij and Dawson are similar to 
the two frameworks described above. However, similar to Kass, Verweij have stressed 
certain elements: that there should be just distribution of benefits and burdens, 
participation should generally be voluntary unless compulsory vaccination is essential to 
prevent concrete and serious harm and public trust in the vaccination programme should 
be honoured and protected.  
 
South Africa uses a similar framework in the decision for introducing new vaccines into 
the EPI.  A detailed process is engaged with the contribution of experts who consider all 
the issues brought up in the ethical and decision making framework. A group of experts 
considers these areas, and makes a recommendation to the Department of Health to 
include a vaccine in the universal programme. (Ngcobo, Cameron submitted for 
publication SAJEI). Therefore the immunisation programme in this country and many 
countries that follow WHO guidelines is based on ethical principles for public health 
programmes.   
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4. Ethical Basis for Immunisation 
4.1 Ethical Theories that Support Immunisation 
Utilitarian: Consequence Based Theory 
 A universal immunisation programme has the primary goal of decreasing the incidence 
of vaccine preventable diseases (VPDs) by protecting individuals and communities. It is 
focussed on utility in that it seeks to maximise collective goods. As the utilitarian ethical 
theory is based on the fundamental principle that an act is right if it produces the best 
overall results, it forms the ethical basis and justification for public health interventions 
(Coughlin 2006:16; Beauchamp 1994:55). This reasoning is supported by successful 
immunisation programmes showing that 1) the universal immunisation programme has 
shown that it saves lives 2) the  saving of lives is a good so 3)  the consequences of the 
action (of universal immunisation) to save lives is a  good .   
 It is simple to understand the moral justification of utility and generally easy to apply. 
According to this approach we may overlook the rules and maxims advocated by 
deontologists, rather we seek to only to act towards the production of the greatest 
amount of utility (happiness, good or pleasure) for the greatest number of people; the 
maximum benefit for all concerned. This means that in pursuing to maximise the good 
(the utility) for the greatest number of people, we may trump other considerations such 
limiting individual rights8 when it is for majority benefit. In the case of immunisation 
programmes for example, because the success of the programmes rests in its ability to 
modify the epidemiology of VPD, it relies on a high level of vaccine coverage (Schoub 
2002: 47).  So a decision to immunise will weigh heavily on the positive balance for the 
                                                 
8  As noted earlier, this does not mean that we are insensitive to human rights, rather, societal rights may 
trump those of the individual, a point I will discuss later.  
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overall good for society. In this way, we can see the applicability of the principle of utility. 
Likewise, it must be said, that if society perceives immunisation as a negative, fails to 
immunise, and a disease epidemic occurs, the consequences of this action will be wrong 
as the overall consequences are bad for society.9  
A universal immunisation programme is morally grounded on providing the maximum 
benefits for the population and individuals. This is not only backed by the expected 
results of herd immunity but also by the guiding principles in the decision making 
process on implementation of a universal immunisation programme, including cost-
effectiveness. The principles used for decision making on new vaccine introduction for 
universal immunisation, already discussed are grounded in this ethical approach. 
Immunisation services based on these principles and the risk-benefit analysis have a 
strong moral basis grounded on the utilitarian theory. 
The application of this theory to the immunisation programme in South Africa is well 
fitting as the achievements of immunisation in this country are in keeping with the global 
achievements and include; the interruption of wild poliovirus transmission, tetanus 
elimination and control of conditions like measles and haemophilus influenzae type b. 
(Ngcobo 2008: 9-13). These conditions in the past caused a lot of suffering, disability 
and death.  
 
 
 
                                                 
9 See earlier reference (Gangarosa 1998), concerning misperceived risk and outcome in a Japanese 
pertussis epidemic. Also an example of localized outbreaks caused by failure to consider the whole of the 
community is exemplified in a measles outbreak in the USA (May 2003).  
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Communitarianism 
Immunisation also finds a strong moral basis in communitarianism. Communitarians 
maintain that acts are right and justifiable depending on: their communal value, the 
common good, the social goals, traditional practices and cooperative value (Beauchamp 
1994: 77).  Conventions, traditions and social solidarity are valued by the members of a 
community. According to communitarians, as long as society values certain practices 
and believes in the collective benefits of those practices, individuals within a community 
are morally obliged to such practices. Communitarians will advocate for limiting freedom 
of individuals for the sake of common good and public interest (Callahan 2002). This 
may mean that practices valued by society may be enforced. As universal immunisation 
services are provided for public protection, many communities would be concerned 
about the devastating effects of infectious diseases and would desire protection, when 
such protection is available. 
 
Beauchamp and Childress (1994: 82) state that communitarians will recommend laws 
that will make organ procurement a community project by promulgating the presumed 
consent laws. Accordingly it would be assumed that individuals and families donate the 
needed organs of a deceased person, unless they have filed an objection. Based on this 
reasoning and applying the strong allegiance to community values, it is evident that 
communitarians should find parents obliged to immunise their children and would be 
expected to favour laws that make immunisation compulsory. 
 
There is little doubt that most societies in this country value immunisation and its 
benefits. There are however reported isolated incidents of communities in North West 
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province and KwaZuluNatal, that have refused to participate in mass immunisation 
campaigns in the past (personal communication with North West and KwaZuluNatal EPI 
Provincial Managers, 2007 following the national polio and measles campaign). 
However, there has been no indication of refusal of routine services.  
.  
The communitarian theory will not support universal immunisation in cases where the 
whole community is opposed to immunisation, if a majority in a community perceive 
more harm than benefits. The northern states of Nigeria who had misgivings about the 
polio vaccine and consequently refused to participate in the polio immunisation 
campaigns aimed at polio eradication, provide such an example (CDC 2005:873-877). It 
is worth noting that, when communities have refused immunisation it is not so much 
because they do not value protection from the targeted diseases but refusal is 
commonly due to broken trust between the community and the providers of the service, 
as was the case in Nigeria.   
 
Communitarianism is similar and encompasses a similar notion to the utilitarian 
approach, as both are directed at public good for a community. However, with the 
utilitarian approach government officials or outsiders can make the decision about what 
is good for a community, whereas with communitarianism the value of utility must be 
appreciated by the community itself.  
 
Daniel Callahan (2002: 169-196) supports the Communitarian approach for public health 
interventions. He opposes a decision making process based on individual rights, as he 
maintains: 
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“We should enact public policy from a shared consensus about good society, not on the 
basis of individual rights. Liberal assumptions about state’s neutrality should be scrapped 
and society should be free to implement substantive concept of the good. Biomedicals 
should use communitarian values to implement or revise social laws and regulations 
governing the promotion of health, the use of knowledge ….. In each case the question 
to be asked is: What is most useful to a good society? Not . .. Does it violate autonomy?” 
  
This report maintains this view and concedes that may be the communitarian approach 
in combining utility and community values provides a stronger moral justification than a 
pure consequentialist approach.  With this approach a public health programme is not 
only based on utility, which is an important element; but it is perceived to be of value to a 
society, therefore a public health intervention based on communitarianism should enjoy 
community support. This will be better achieved if the community is involved in decision 
making and in setting priorities in public health programmes as suggested by Callahan.  
 
According to communitarianism, the society and the state in an effort to secure societal 
good should be able to implement laws that safeguard the public good and the 
environment without being restricted by the individual rights. In South Africa there is 
limited if any community involvement in decision making on provision of immunisation 
services, at national level which is responsible for setting policy. There are ongoing 
efforts at service delivery (facility) level to have Clinic (Facility) Committees. The 
existence of functioning committees varies widely from area to area. It is doubtful if one 
can consider their existence to represent meaningful community involvement in service 
delivery, albeit a significant step.   
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Both the utilitarian and the communitarian theories bring up an important moral criterion 
on benefit to society which sets them apart from the other theories. The application of 
the communitarian theory in our setting will help introduce a procedural requirement of 
involving the community in decision making. This may be a significant step in that it will 
address the element of trust and acceptability of a universal immunisation programme, 
by so doing position EPI strongly against any future adversaries, particularly the anti-
vaccination lobbyists. 
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Kantianism 
The deontological ethical theory based on Immanuel Kant’s philosophy is one that can 
be considered to support compliance with universal immunisation services. Immanuel 
Kant insisted on a categorical imperative that declares certain actions or inactions as 
necessary. The categorical imperative should guide reasoning and decisions, even if we 
accept that we may not be able to carry out certain acts (Hill 2000: 227-246).  The 
categorical imperative is differentiated from a hypothetical imperative, where a 
performance of an action is directed at purpose to achieve specific desired results; “Do 
A in order to achieve X’. The categorical imperative on the other hand is binding, 
irrespective of the consequences. It demands an action for its own sake and places an 
absolute moral demand. Therefore, we should accept a categorical imperative as a 
sufficient and overriding reason to act in accordance with its demand. Acting in 
accordance with a categorical imperative does not consider one’s desires or personal 
ends and may very well be in conflict with our interest. (Hill 2000: 236) 
 
Kant further reasoned that we do good because of its intrinsic good, good that is not 
affected by circumstances neither is it dependent on any condition. He maintained that 
the ultimate principle of morality must be a moral law that can guide us to the right action 
under all circumstances. With this he came up with the concept that a moral law should 
have the property of universalizability. An act that cannot be performed by others with 
the same moral acceptability cannot be regarded as morally acceptable.  (Kant 1785) 
 
“Act only according to that maxim whereby you can at the same time will that it should 
become a universal law.”   
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Kant’s analysis is that, we should not treat others as means only to our ends but we 
should treat others as ends in themselves. He based this on the premise that a free will 
is the source of all rational action and to treat it as a subjective end will deny the 
possibility of freedom in general. Therefore it would contradict the universal law to claim 
that a person is merely a means to some end rather than always an end in his/her own 
self.  
When we consider Kant’s position on these points and relate that to immunisation it 
becomes evident that, immunisation is an act that is universalisable, due to the fact that 
immunisation requires public cooperation to be effective. Therefore opting out of 
immunisation cannot be a universal act in any community.  Dawson constructs a similar 
argument based on Kant’s moral reasoning. He points out that Kant’s categorical 
imperative demands that we think about the implications of our actions on the whole 
community (Dawson 2007: 175).   
 
According to Kant, we may be morally obliged to conduct certain acts not because of 
their benefits to anyone, but merely because it is morally required of us; the categorical 
imperative.  The moral requirement that Kantians can be presumed to have imposed on 
themselves as prescribed by: the categorical imperative, the universality of moral law 
and to the need to treat humanity not as a means but always as an end,  demand that 
they comply with the universal act of immunising children. The universalizability of 
immunisation is further substantiated by that Kant insisted that people have a duty not to 
act by maxims that create inherent or impossible states of natural affairs when we 
attempt to universalise them (Kant 1785).  
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Kant insisted that as moral agents and rational agents we have autonomy. The concept 
of being bound to act according the demands of a categorical imperative is despite 
Kant’s strong rhetoric for individual autonomy.  Hill (2000) clarifies that the autonomy 
advocated by Kant allows one to understand the categorical imperative and the reason 
behind the imperative. The categorical imperative should be self imposed; it should not 
be mere compliance with externally exerted pressure. Furthermore, according to 
Kantianism an act should not be conducted because it is prudent to do so nor because 
of its utility. This will mean that the autonomy advocated by Kant, does not support 
acting against the demands of moral maxims. It is the freedom to act within certain laws 
that one has created for oneself. It means subjecting one to the constraints of the 
categorical imperative autonomously with the full understanding of the reason of the 
maxim even if does not serve our interest. Applying Kantianism therefore morally obliges 
us to immunise our children, if we accept immunisation as a categorical imperative that 
is universal.  
 
Furthermore, according to this theory we will comply with such a programme with our 
free will, autonomously understanding that it is not necessarily for our own ends. This 
means that in countries where immunisation is legally enforced, one will participate 
because it is morally right to do so, not merely respecting the law. According to Kant, it is 
not morally praiseworthy to act in accordance with the law, one must act in accordance 
with a categorical imperative, fully embracing a particular maxim independent of external 
enforcement. Although it is clear that the Kantian theory should form a strong basis for 
universal immunisation programme, reports are that Kant was critical of smallpox 
vaccination (Dawson 2007:175). This however illustrates the limitations of the theories 
and the poor application of principles by the very people who prescribe them.  
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4.2 Early Philosopher, John Stuart Mill 
The moral reasoning of John Stuart Mill a widely quoted early philosopher, who believed 
in individual liberty provides a strong moral justification for a universal immunisation 
programme. Of direct relevance is Mill’s “harm to others principle”. According to Mill the 
sole purpose for which power can be exercised upon any member of a civilised society, 
is to prevent harm to others. This, he referred to as the “harm principle / harm to others 
principle”, the principle that is supposed to govern the dealings of society with 
individuals (John Stuart Mill 1869).  
Bayer (2004) indicates that public health interventions have been justified with the 
invocation of the harm principle, which was first enunciated by John Stuart Mill. The 
harm principle therefore, provides the standard for judging liberty limiting acts of 
governments.  Bayer goes on to say that limitations of individual rights in the face of 
public health threats are firmly supported by legal tradition and ethics. To this end the 
consequences of lost herd immunity pose a serious threat of “harm to others”.  
Furthermore, in the case of refusal to immunise a decision is taken on behalf of children, 
who either cannot or have not consented to this imposed harm on themselves as well as 
to others who may be affected. 10 May (2005) maintains that the threat of harm to others 
will significantly alter the autonomy based considerations, as restricting autonomy rights 
is a necessary component of a liberal constitutional system that seeks to balance the 
interest of diverse individuals who have a plurality of values.   
 
                                                 
10 The significance of harm to others posed by opting out of immunisation is highlighted by a number of 
writers particularly with reference to outbreaks where coverage is low and amongst those eligible for 
exemption from mandatory immunisation Dawson 2007; May 2005; Bradley 1999, Gangarosa 1998 and 
Freed 1996. 
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Mill (1869) on Liberty maintained that individual rights and actions cannot be considered 
independent of their utility.  
“I regard utility as the ultimate appeal on all ethical questions; but it must be utility in the 
largest sense grounded on permanent interest of man as a progressive being. Those 
interests, will authorize the subjection of individual spontaneity to external control in 
respect to those acts which concern the interest of other people. If anyone does an act 
hurtful to others there is a prima facie case for punishing him by law, or where legal 
penalties are not safely applicable by general disapprobation. There are also many positive 
acts for the benefit of others, which he may be rightfully compelled to perform; such as … 
to bear his fair share in the common defence, or any other joint work necessary for the 
society of which he enjoys the protection…”   
 
The interpretation of Mill’s reasoning has significant moral implications for participation in 
a universal immunisation programme. He points that acts may be punishable or 
forbidden if they cause harm to others. He refers to positive acts for the benefits of 
others which an individual may be rightfully compelled to perform if he enjoys that 
protection, as quoted above. This accordingly, applies not only to action but to his 
inaction as well, as one may cause evil to others not only by his action but also by his 
inaction. In either case he is justly accountable for the injury that may result. (Mill, 
1869)11 
 
Therefore one cannot use individual liberty as a defence for opting out of an intervention 
programme that has clear benefits for society that all enjoy. In the case of immunisation 
opting out may eventually lead to harm to society as a result of outbreaks and human 
suffering that follows. This has specific relevance for many diseases targeted by the 
immunisation programme in South Africa, which have not been eradicated, like measles.  
                                                 
11 Mill’s position on harm to others by one’s action or inaction is despite his strong rhetoric for individual 
liberty and the importance Mill attached to individual freedom. 
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Mill in his work,  “Of the Limits to the Authority of Society over Individual”, considers the 
issue of relationship of society and individuals that such a relationship is not based on a 
contract and further concedes that it will serve no purpose to create such a contract. 
However, the point is clear that everyone who receives protection from society has to 
pay it back somehow:  
“Even though society is not founded on a contract and there will be no good purpose 
answered by inventing a contract in order to deduce social obligations from it, everyone 
who receives the protection of society owes a return to society for the benefit. The fact of 
living in society makes it unavoidable that each member of society is bound to observe a 
certain line of conduct towards the rest. ….. This conduct consists of not injuring the 
interest of another…… each person bearing his share (to be fixed on some equitable 
principle) on the labours and sacrifices incurred for defending the society or its members 
from molestation and injury. These conditions, society is justified in enforcing at all costs 
to those who endeavour withholding fulfilment. Conduct may not just be hurtful to others, 
it may be lacking in consideration of the welfare of others. Whenever there is a definite 
damage or a definite risk of damage, the case is taken out of the classification of liberty 
and placed in that of morality or law.” 
 
This is one of the most convincing analysis on moral justification to comply with the 
demands of a public health programme. It highlights that individuals owe society for the 
share individuals enjoy in common defence and for this he must in return play his part 
for the good of society. Opting out of a public health programme whilst enjoying  the 
benefits is directly attacked. Mill concurs with communitarianism in that society can 
enact legislation to demand actions that will promote the interest of society. This moral 
reasoning provides the basis for making immunisation compulsory. Mills reasoning 
encompasses the necessary dimensions for immunisation justification as it combines 
utility and communitarians; relates to utility of acts on others, whilst grounded on liberty.  
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4.3  Principle Based Approach  
It is compelling to consider the Principlist approach,  “Georgetown model”  and see how 
the immunisation programme in this country could be evaluated based on the well 
known 4 principles of: beneficence, non-maleficence, autonomy and justice outlined by  
Beauchamp and Childress (2004).   
 
The principle of beneficence requires that a practice should benefit recipients. For public 
health programmes, beneficence requires that society should benefit. Immunisation 
services fulfil this principle as extensively outlined. The benefits conferred by 
immunisation for individuals are so strong that, the practice is considered to be in the 
best interest of the child. In cases where parents have refused to immunise their 
children, courts have used this concept of the best interest of the child to demand that 
children be immunised. 12 This also applies to refusal of life saving treatment based on 
religious beliefs. 13 Furthermore, the decision making process for universal immunisation 
is grounded in the principle of beneficence in that the focus is on utility and thus on 
benefits to individuals and society.  
 
The principle of non-maleficence is considered and applied in the decision making 
process for universal immunisation and is covered through safety consideration which is 
an important element of this process. Stringent licensure requirements are in place for 
                                                 
12 In the US courts have not hesitated to reject religious objections to vaccination or to over rule parents 
decision to further the interest of the child based on Parens Patriae. Malone 2003 ; Cude v State, 237 Ark 
927 (1964); Prince v. Commonwealth of Massachussets,  321 U.S. 158 (1944) and Wright v De Witt 
School District , 238 ark 906 (1965). Prince’s case is that of Jehova’s Witness,  
 
13 This is the case with Jehova’s Witness followers, and parents may refuse blood transfusion on religious 
grounds. In 2005, Judge W. Seriti granted doctors at Pretoria Academic Hospital a court order to transfuse 
a month old baby whose life was perceived to be at risk ( Zelda Venter 2005)  
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vaccines generally in all countries. South Africa has additional local safety requirements 
by the Medicines Control Council (MCC), highlighted elsewhere in this report. This 
requirement forms part of fulfilling the non-maleficence principle. However, the principle 
of non-maleficence can be further fulfilled by establishing a compensation system for 
those who are affected by severe adverse events following immunisation with grave 
consequences like disability. This is discussed further under the specific challenges for 
South Africa. 
 
The rendering of the immunisation services is based on the principle of justice. All 
children in the targeted age group, below 5 years are the beneficiaries of the 
programme; irrespective of where they come from, race, religion or socioeconomic 
circumstances. The provision of free immunisation services further fulfils the principle of 
justice. No one is excluded from immunisation services, save only for the limitations of 
infrastructure and resources that render access to health services difficult in some 
disadvantaged communities.14 Furthermore the immunisation programme is structured 
such that no specific groups or individuals are made to bear an unequal burden in terms 
of risk or any other foreseeable burden; therefore there is a just distribution of burdens. 
 
The principle of autonomy is also respected in that participation in immunisation is 
voluntary in this country. Where there has been resistance, negotiations and developing 
understanding has overcome initial obstacles. Refusal by some communities to 
participate during immunisation campaigns is addressed by negotiations and providing 
clarity and information on the programme. However, it is well accepted that principles 
                                                 
14 There are ongoing efforts and community collaboration allow for means to be established for health 
services to reach such communities. Remote communities are reached through the use of mobile services. 
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will often be in conflict and when there is a conflict of principles the goals of the 
programme have to be overriding. Quite often one principle will override the other/s as it 
commonly happens in clinical medicine.  
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4.4  Theories that Oppose Universal Immunisation 
Liberty: The Rights Based Approach   
The Right Based approach and the theory of liberty bear an interesting and apparently 
strong stand against public health programmes, particularly enforced programmes. The 
origin of rights and the concepts of liberty were to provide protection of individuals from 
the state power which at times could be unlimited and provide protection against 
unequal treatment, intolerance, arbitrary invasion of privacy and help ensure protection 
of life, expression and property.15 Rights and the concept of autonomy formed the basis 
for bioethics due to initial focus of bioethics on the abuse of medical research subjects, 
doctor – patient relationship which was originally paternalistic and the development of 
high technology medicine (Bayer 2004; Callahan 2002). However depending on the 
basis of one’s argument, rights may also be used to justify the provision of immunisation 
services including compulsory immunisation.    
 
Liberals will argue that parents have a right to autonomy and to have their decisions 
about the health care of their children respected. Furthermore Parental rights to decision 
making for their children and the duty of care for their children is well acknowledged.  
Imposing universal immunisation and services offered without provision of adequate 
information may be seen as violating parental rights to this freedom of will.  
                                                 
15 The movement for human rights gained more recognition following the atrocities of the Second World 
War. In 1948 the United Nations adopted the Universal Declaration of Human rights. This was later 
followed by 2 main treaties: The International Covenant on Civil and Political Rights and the International 
Covenant on Economic, Social and Cultural Rights. (Int. Federation of the Red Cross 1999) 
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Parental autonomy should be considered in tandem with its consequences, of loss of 
herd immunity which may pose a serious threat of “harm to others”.16  There are two 
groups that may be exposed to harm if the parents decide not to immunise their 
children: their own children and other children in the community. The application of the 
harm principle will apply to both groups and has significant bearing on the right to 
autonomy. According to May & Ross (ibid), the threat of harm to others will significantly 
alter the autonomy based considerations. They point out that the “harm principle” forms 
the basis for restricting autonomy in liberal societies. Restricting autonomy rights is a 
necessary component of a liberal constitutional system that seeks to balance the 
interest of diverse individuals who have a plurality of values.   
Furthermore, when parents fail to provide reasonable adequate care for their children, 
they relinquish the right to rear and make decisions for their children (Malone, 2003). 
Refusal to have one’s children immunised may very well amount to this kind of parental 
failure to provide adequate care for one’s child which may result in harm to one’s own 
children. This is similar to other situations where parents fail to act in the best interest of 
their children, like the practice of Jehovah’s Witness which extends parental refusal for 
their children to have blood transfusion. Whilst the law regards parents as the legitimate 
decision makers on matters that relate to their children, the law will not hesitate to take 
action in the best interest of the child, should courts be convinced that the parents are 
failing in their duties. 17 
 
                                                 
16 The concept and effects of harm to others as it relates to children who cannot take such decisions has 
been discussed. 
17 See reference 12 and 13 above. 
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The liberals will maintain that the public and individuals have a right to be informed 
about the benefits; the risks involved so as to give their informed consent and may 
demand that an acceptable level of privacy be provided. This will mean that when 
services are provided the information on the rights of parents to refuse immunisation will 
be provided at the same level of emphasis as the information on benefits.  
 
Governments have a responsibility to fulfil this duty. Resource limitations in South Africa 
and other developing countries do not allow the provision of services that will satisfy this 
kind of standard. Clements and Ratzan (2003) appreciate these limitations. They 
indicate that the constraints lead to limited disclosure of information, particularly where 
literacy levels are low and the danger of the infectious diseases prevented by 
vaccination is much higher than the risk of the vaccines. Under such circumstances the 
priority should be to offer protection than to dwell on the rights of individuals to full 
information. This is in contrast to areas where a condition like measles is rare, resources 
are adequate, the parents in this setting will require much wider discussion and 
information.  
 
Concerns have been raised about the quality of information provided by the 
immunisation programme and the tendency to overstate the benefits whilst down playing 
the risks (Paul 2005). Although information provided may be considered incomplete, on 
the other hand, providing too much information in our setting may amount to truth 
dumping, which could have undesirable consequences. Information to a parent about 
the 1 in a million encephalitis cases associated with measles vaccine, is likely to end up 
with an alarmed parent who will not have her child immunised.  Callahan (2002), states: 
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“Vaccines are as safe as humans can presently make them. Yet in any health 
intervention, some level of uncertainty will always remain. It is not easy to present this 
concept accurately and ethically to the public without driving the impression that 
vaccinations should be avoided.” 
The main question is ‘How much information on risk and side effects should be shared 
with parents and caregivers?”  Specific country circumstances are of relevance. Whilst 
parents and care givers should be given adequate information for decision making, it still 
has to be established “How much is adequate?”  The consequences of providing too 
much information as well as the practicality of providing detailed information should be 
considered. There is a need to strike a balance between the public’s  right to know,  the 
duty of the government to a needed immunisation programme and the obligation of  
individual health professionals to inform.  
 
The Rights Based approach should not only apply to opting out of interventions, children 
have rights to intervention programmes aimed at reducing morbidity and mortality. Public 
health programmes have over the years adopted the right based approach and this 
move has been supported by the international agencies like UNICEF. The Application of 
the rights in this context is in sharp contrast to using rights to disclaim the ethical 
position of universal immunisation. The Rights Based approach to providing 
immunisation services maintains that “Every child has a right to immunisation.”  This 
approach is more concerned about the number of children who are not reached by 
immunisation services and are denied their rights protection (Jonsson 2003: 31-43). 
 
When properly analysed the Rights Based approach provides a strong basis to advocate 
for quality services of an acceptable ethical standard. Whilst this may not be realised 
overnight, these areas should be addressed so that services progressively approach this 
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standard. It should be highlighted that in our setting it may be misleading to consider 
such areas as primarily ethical issues rather than as issues that relate to constraints in 
service delivery.  
Kantianism  
Whilst Kantianism as considered earlier should provide a strong basis for universal 
immunisation services, others may look at this theory as providing a basis for opting out. 
Kantianism stresses individual autonomy, and can be viewed to support the right of 
parents to make decisions on the matters of their children. Some may be inclined to 
interpret this to mean that, autonomy should give individuals a free will to opt out; if the 
autonomy is not fully understood as being subject to a categorical imperative.  
The practical setting in which the services are offered may cause misinterpretation. 
Kantians may conclude that the immunisation service fails to abide by the categorical 
imperative of providing full information. However,  considering the universal nature of the 
immunisation, a core element of a moral action according to this theory, the limitations of 
health services cannot provide ground for actions that cannot be universalisable. 
It is doubtful that Kantians will be concerned about risk analysis and cost-effectiveness, 
as they are not concerned about the consequences. It is interesting to consider the 
position of Kantians when they consider the “best interest of a child”. The principle of 
justice and considering the best interest of the child may be another dimension in the 
rules and categorical imperatives that Kantians should consider. This aspect should 
further tip the scale for Kantanians in favour of universal immunisation.  
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There may be a conflict of maxims: the respect for parental decisions and the best 
interest of the child. However, the overriding maxim should be one that is universalisable 
and should treat people as ends in themselves.  The conflict of rules or what can be 
considered categorical imperatives in such a case, demonstrates the limitations of this 
theory, particularly in relation to public health programmes.  
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5. Repudiation of Ethical Objections to Immunisation  
This chapter looks at the main arguments used to disclaim the ethical basis of a 
universal immunisation programme. The aim is to analyse and refute such claims. Some 
concepts will resurface as they are considered  in detail in the process of repudiating the 
arguments of ethical objections to a universal immunisation programme.  
5.1 The Nature of Immunisation and Moral Conflicts 
Apart from the setting in which immunisation services are offered, the intrinsic factors in 
the nature of the immunisation programme bring up major moral and legal conflicts. The 
intrinsic factors include the following: immunisation is given to healthy individuals with 
the aim of preventing a disease, which may or may not affect that particular individual 
immunised; the benefits of immunisation are not just for the individual but are also for 
the community – due to herd immunity that develops when a large number of individuals 
are immunised; the herd immunity benefits include protection of individuals who are not 
vaccinated as well as those who were vaccinated but did not develop the desired 
immune response. The main objection presented by some is that universal immunisation 
infringes on individual liberty and specifically compulsory immunisation violates 
individual rights afforded to individuals by the constitution. To this end the programme is 
considered paternalistic and coercive. 
 
Further complicating matters is that immunisation is not completely without risk, there is 
a risk of side effects from the vaccines. The more common side effects are generally 
minor, like local swelling and pain at the injection site, fever and irritability. Serious side 
effects like encephalopathy may occur on very rare occasions. Furthermore it cannot be 
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predicted with any level of certainty, as to who will get the side effects after exactly how 
many doses of a vaccine. We do not know for sure what the exact figures and incidence 
of side effects are; quite often figures are given as a range which varies widely from one 
setting to another.  Similarly we cannot be sure at what level of population immunity an 
outbreak of say measles will occur. 18 
 
The following section considers each point of the argument raised and shows that there 
is strong moral and ethical justification for universal immunisation. The key elements of 
the argument presented by Dawson (2004) are used.  Key elements: 
a) Preventative public health programmes like immunisation are performed upon 
asymptomatic individuals, 
b) A public health intervention like immunisation will carry some risk of harm, 
c) Risks are carried by individuals yet benefits lie at the level of populations 
The conclusion: Such prevention programmes are unethical, given the distribution 
of risk and benefits.   
 
5.2 Risk and Benefit for Healthy individuals 
 Following on the key elements highlighted above, one of the arguments brought up by 
those opposed to universal immunisation is that healthy individuals, who do not have a 
disease, take personal risk for a condition that may not affect them. Dawson refers to 
this as the “prevention paradox“(Dawson 2004).  According to this argument, healthy 
individuals are subjected to an unjustifiable level of risk from a vaccine which aims to 
                                                 
18 The uncertainty that affects public health programmes, which relates to the uncertainty of science has 
been acknowledged by writers, Callahan (2002) and Blum (2006: 273-281). 
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prevent a disease that has a low risk, and even if one were to get the infection it is 
argued, it is not serious (Clements 2003).  The other area of concern brought up is that 
healthy individuals cannot be expected to tolerate risk from immunisation in the same 
way one tolerates risk from treatment of a condition that has affected that individual.   
 
The argument presented is: One cannot tell who amongst the immunised, would have 
been infected and who will be protected and thus receive the benefit of immunisation, 
yet harm or inconvenience is borne by all. Whilst any individuals may be harmed, the 
benefits will be for a very few unidentifiable individuals. So, according to this argument, 
benefits are few and distant, even likely to be nonexistent; whilst any potential of risk 
clearly exists; the “prevention paradox”. 19 
 
Refuting this argument 
 
Anyone who argues along these lines is arguing from the safety net of the current levels 
of protection from VPDs enjoyed by many countries based on high levels of population 
immunity. In South Africa such an argument cannot be valid. Even in developed 
countries such an argument may not be valid. During the years 2003 -2005, South Africa 
experienced a huge measles outbreak, which affected five of the 9 provinces. The 
annual number of confirmed measles cases over these 3 years ranged from 251 to over 
830 cases. Prior to this South Africa had reached a stage where the annual number of 
confirmed measles cases was less than 60 with an average 29-30 confirmed cases per 
year (Ngcobo, 2008). Based on the level of measles control the country had reached 
prior to this outbreak through the implementation of WHO recommended strategies, 
                                                 
19  As pointed out by Dawson on reflection of Rose’s argument (Dawson 2004) 
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South Africa was considered to have eliminated measles (Biellik 2002:1564-1568). The 
propagated measles outbreak was associated with significant morbidity, a number of 
hospital admissions and some deaths. 20 
 
Similarly, the experiences of other countries like Japan, UK, US and Russia (already 
cited) further illustrate that such outbreaks do occur and can result in significant 
setbacks, which may take a country years to recover. In countries where the level of HIV 
infection is high, the health consequences of a measles outbreak are much more 
serious with a much higher case fatality ratio (Moss 2003).   
 
The point to bear in mind is that, the purpose of a prevention programme is to preserve 
a healthy state of individuals; otherwise anyone who is healthy today may not be healthy 
tomorrow unless certain measures have been taken to preserve that healthy state. It 
should be stressed that the risk from infections like measles and pertussis, which have 
not been eradicated and are easily transmissible by droplet spread remains significant. 
This applies to developing and developed countries as seen with the measles outbreak 
indicated above. This is true even in countries where the current incidence of such 
infections is low. The risk of outbreaks from importations and re-emergence of local 
strains become a threat when the level of population immunity drops. Therefore element 
(a) above: the programme is performed on healthy individuals, who are presumed to 
face little risk from the disease targeted by immunisation, is not valid.  
 
                                                 
20 The actual number of deaths could not be determined due to the compounding factors of HIV and AIDS 
infection.  
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Furthermore, to say that we cannot predict the individuals who will be affected by a 
disease and consequently be the main beneficiaries of immunisation does not carry 
weight. It is well documented that as population immunity drops disease outbreaks 
occur.  Notwithstanding the fact that measles will practically affect all those exposed who 
are not immune (Christie 1980:357-386). 
  
Let us consider element b: Immunisation will carry some risk of harm. Implicit in this 
argument is the assumption that the risk from immunisation is higher than the risk of the 
disease it is meant to prevent.  In the preceding paragraphs we have already addressed 
the fact that conditions like measles cannot be said to carry a low level of risk, certainly 
not in this country. Let us now consider the risk carried by immunisation. Whilst it is well 
accepted that vaccines carry a level of risk like any medical intervention, it should be 
pointed out that vaccines are safe. They are as safe as they can be currently 
manufactured and undergo stringent safety verification before licensure. To put the 
matter into perspective; the risk of encephalitis is one in a million doses of measles 
vaccine, yet the risk of encephalitis from measles infection is 1 to 2 per 1, 000 measles 
cases, which is 100 times higher (Kimmel 2002: 2113-20; Patja 2000: 1127-1134). Other 
serious complications of measles like subacute sclerosing panencephalitis carry similar 
ratios, apart from that there are no deaths conclusively associated with the measles 
vaccine in well infants.  It is evident that the risk from this disease is much higher and 
carries much more serious health consequences.  
 
Based on the empirical evidence of the risk of a disease compared to the risk of a 
vaccine, the argument that the risk from immunisation is too high compared to the 
disease itself, cannot be based on risk–benefit analysis using empirical evidence of 
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country experiences of outbreaks following a decline in coverage levels. One cannot 
claim that a condition like measles is generally not serious. Certainly not in our setting 
where many are at high risk including those who are: immuno-compromised, under 
nourished and may have underlying conditions. Measles carries significant morbidity and 
mortality particularly in such high risk groups.21 In South Africa with the high incidence of 
HIV/AIDS, a high prevalence of under nutrition, measles is indeed a serious condition. 
 
The point of a risk of a disease versus risk of a vaccine becomes even more significant 
when we consider that everybody could wish to avoid immunisation on these grounds. 
Every parent could say; “I do not have to vaccinate my child it is only for the good of the 
community, it will not benefit my child, who will run the risk of the vaccine.” what would 
be the outcome in terms of outbreaks and re-emergence of previously controlled 
diseases. If this were the standpoint of all parents, the whole scenario changes. Such 
arguments are brought up in the comfort of knowing that a large majority still vaccinate 
their children, so an objection is brought up whilst enjoying the safety of herd protection. 
This is a free riders argument, based on an action that is not universalisable.  
 
The argument, of free riders is supported by Dawson (2007) on: “The Existence of Herd 
Protection and the No Additional Benefit Argument.” Dawson argues that where herd 
protection exists there is no harm done to others (third parties), therefore an individual’s 
decision not to vaccinate does not harm anyone. His argument is that, where there is no 
herd protection individuals have a moral obligation to vaccinate. However he reasons 
that where there is already herd protection which he acknowledges as a public good, 
                                                 
21 A high level of morbidity and mortality associated with measles is seen in developing countries 
(Christie 1980). 
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established by the actions of others and everyone receives a share of it, in such cases 
an individual may opt out if he wants to. He claims that there is no additional benefit to 
others and vaccinating against one’s inclination in such a situation is a futile action of 
conformity. The points already discussed clearly dismiss such an argument.  It’s a free 
riders argument that is permissible for a few. An exceptionist’s argument that hopes that 
one is an exception and no one else does the same.  Furthermore it does not consider 
that a state of herd immunity is not static it changes all the time, particularly when some 
people eligible for immunisation prefer to opt out. The point is, “when will one know that 
so many of us have opted out to a level where herd immunity is lost, one must now be 
immunised?”  What measure could be used to find this point in the level of immunity?   
 
5.3  Individual Protection versus Herd Protection  
In this section we will consider the third element (c): Risks are carried by individuals, yet 
benefits lie at the level of populations. Dawson (2004) on the prevention problem has 
presented a strong argument that refutes this element. This element of the argument (c) 
may be considered strong based on the claim that immunisation benefits the public 
whilst there is little individual benefit and the individual bears the risk of harm. Such an 
argument may create resentment amongst the public and may be a stronghold for those 
who promote liberty, who may be intent on opposing public health efforts aimed at 
benefiting society. Their concern is that individual benefit is small and even uncertain. 
This report disputes that.  
 
Whilst immunisation gives the public benefits of herd protection, immunisation also 
protects a large percentage of individuals immunised (accepting that vaccines are not 
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100% efficacious). The fact is those who are vaccinated are protected from the targeted 
disease. The immunity generated by vaccination primarily protects the individual; it is 
only when an aggregated large number of immunised individuals at a certain percentage 
that herd protection results. Therefore, there can be no herd immunity without individual 
immunity. Herd immunity is a secondary benefit.  Dawson (2004) highlights that, some 
individuals benefit and (this report adds) a significant majority are protected if one 
considers the risk level already discussed. Individual protection is a direct benefit that 
should not be overlooked.  
 
The fact that benefits and impact of a public health programme are measured at 
population level may cloud the point of individual benefit. Dawson maintains that, 
although we cannot identify the individuals in advance who will get the infection and thus 
be direct beneficiaries, individuals still enjoy protection. The response to this point is, “It 
is not necessary to identify such individuals.” This is a share that each person has in the 
existence of herd protection as a public good 22 This point becomes clear if we consider 
measles outbreak in a virgin population, which affects everyone who is not immune as 
already discussed (Christie, 1980). Even if we could identify such individuals, this would 
be a futile impractical exercise that would defeat the major goals of immunisation, like 
disease eradication.    
 
Considering that immunisation provides herd protection which results in the interruption 
of disease transmission, individuals and communities benefit. Individuals should 
acknowledge this protection from herd immunity, seeing that it is individuals who 
contract diseases and fall sick.   
                                                 
22  Dawson points out the un-excludable goods individuals enjoy, citing Klosko.  (2004) 
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5.4  Social Contract 
This section claims that based on the public good of herd protection conferred by 
immunisation, individuals have an obligation to immunise their children. The utilitarian 
theory, communitarian theory, casuistry, and the harm to others principle all provide a 
strong moral basis for parents to immunise their children. This moral obligation is so 
strong that it has been referred to as a “social contract” (Freed 1996). The social 
contract means that there is an obligation on all members of society to have their 
children immunised as this will result in herd immunity, which will protect those children 
who cannot be immunised for medical reasons, those who are too young to receive 
immunisation and those who experience vaccine failures.  
The social contract exists because individuals have a responsibility to play their roles 
which result in protection of others. The point here is, there are members in a community 
who are willing to be immunised but cannot be due to constraints beyond their influence. 
There are infections which affect and may have deadly consequences in the non 
targeted group. Vaccination of the targeted group results in protection of all including the 
non-targeted that may be saved from death. Examples include immunisation against 
pertussis, rubella and influenza. Therefore, immunisation may have an altruistic element 
(Vernon 2003). All these three infections can either result in death in the non targeted 
group or result in severe malformations of foetuses due to Congenital Rubella 
Syndrome. Vaccination against influenza may be mainly directed at school going 
children but also protects the elderly through herd immunity, who are more likely to 
succumb to the infection. 
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The moral reasoning of John Stuart Mill, discussed earlier, brings clarity on 
understanding the relationship that individuals have with society. Mill strongly protected 
individual freedom and rights, but when it came to utility of one’s actions, Mill considered 
utility to be the main determinant on which to judge one’s actions. Mill points out that we 
accept that individuals do not have to feel connected or to have a contract with other 
members of their community. However, he stressed that individuals have a moral 
obligation to contribute to the welfare of their society from which they reap benefits. The 
point that people may not feel connected to other members of the community and 
therefore feel they do not have to make sacrifice for them, has also been pointed out by 
other writers. (Blum 2006; Bayer 2004)  Nevertheless, this does not prelude individual’s 
obligation to participate in a programme like immunisation that benefits society.   
 
Participation in a public health programme may result in small benefits to individuals. 
What amounts to mere inconvenience at individual level may have huge implications 
and benefits at population level (Brayer 2004).  Immunisation is a good example, in that 
the individuals may not value protection from immunisation yet at population level it 
produces significant benefits. What may seem an inconvenience at individual level, 
taking a child for immunisation, has a significant impact at population level; that of herd 
immunity, disease elimination and even eradication. Most will agree that individuals are 
morally obliged to perform acts that may be an inconvenience and perceived to be of 
little benefit to them, but which carry significant public good 
 
The implications of a Social Contract in relation to the 2003-05 measles outbreak in 
South Africa and its consequences on the non-targeted age groups are considered 
briefly. Measles immunisation is administered to children at the age of 9 months and a 
 59
repeat dose at 18months, in keeping with WHO recommendations for developing 
countries. Children between birth and 9 months of age are presumed to be protected by 
maternal antibodies. However the level of natural immunity and that of antibodies 
amongst women of child bearing is low considering that measles has been fairly under 
control in South Africa and the previous epidemic was in 1992. This means that many 
children below the age of nine months are not adequately protected by maternal 
antibodies. Furthermore, if these children are HIV infected their level of susceptibility to 
infections including measles is high. Similarly children who are above 9 months who 
might have received measles may not have adequately responded due to the fact that 
the vaccine is not 100% efficacious and the high levels of HIV/AIDS infection in this 
country which interferes with serological response to measles vaccines complicates the 
picture further. 23These factors point to a large pool of children who are not protected 
from measles either because of their age, too young to be vaccinated or they were 
vaccinated but did not mount an adequate immune response required for protection. 
Further compounding the issue is that this group of unprotected children are by virtue of 
their age and by their HIV/AIDS status much more likely to suffer severe complications 
from measles infection with high levels of morbidity and death.  
 
The 2003 – 2005 measles outbreak illustrated some of these complications quite well. 
There were a number of confirmed cases during the outbreak that were below 9 months.  
Deaths were reported amongst the below  9 months age group at a higher rate than in  
the age group of children targeted for routine immunisation, the 9 months to 5 years 
(DOH Report Measles Outbreak, 2003-2005). It was difficult to attribute deaths to 
                                                 
23 Placental transfer of maternal antibodies including antibodies to measles may be impaired in HIV infected women 
(Moss 2003:61-70). 
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measles due to cases that had underlying infections/ conditions like HIV/ AIDS. This 
illustrates that once co-infected the effects of measles are severe. There were also 
confirmed measles cases amongst adults over the age of 18 years, who are much older 
than the targeted age group. Adults suffered affected severe measles outbreak 
infections and a few deaths were reported in those with underlying HIV/AIDS.  
 
The setting in South Africa with underlying endemic infections like HIV/AIDS, 
malnutrition place an obligation on all members of society to ensure high levels of 
population immunity that will prevent disease transmission and help protect others who 
may be more vulnerable. The experience of the 2003-2005 measles outbreak, certainly 
points to a social contract in our setting to immunise children. It may be that 
complications that arise, (like the high level of morbidity in the non targeted group) some 
of which are only understood later in the disease evolution, herd immunity may end up 
protecting the adults who refuse to have their children immunised.  
 
It is those actions which are considered small, insignificant or inconvenience by 
individuals that will have the collective effect of producing serious consequences at 
population level and may lead to disaster at national level causing irreversible harm, 
suffering and death. The question is:  Could it be demanding too much of individuals to 
immunise children for their own protection and help society prevent such setbacks?  
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6. Group Refusal of Immunisation Services  
In this section refusal of immunisation services by a community that takes a joint 
decision not to immunise their children is considered.  Group refusal here, refers to 
community refusal; it does not refer or include a group of anti-vaccination lobbyist that 
actively work to discourage communities and individuals not to immunise their children.  
 
Refusal by communities to have their children immunise pose some ethical challenges 
which are distinct from individual refusal. In a case where a community refuses 
immunisation services, the understanding is that the majority in the community is 
opposed to immunisation and thus the decision affects all members in that community. 
The application of communitarianism in this case binds individuals to a community 
decision not to immunise children. A community leader either: political, traditional or 
religious expresses the wish of the community not to participate in the services offered. 
A community decision like this should be respected and a government has to engage in 
negotiations and activities aimed at convincing the group to accept the offered services. 
 
There are a few examples of such group refusal, which include the northern states of 
Nigeria and a local Shona community in North West province, which has on a couple of 
occasions refused to participate in mass immunisation campaigns conducted all over the 
country (NDOH, 2004 and 2000 National Campaign Reports). We will consider closely 
the experience with the northern states of Nigeria as this had far reaching 
consequences.  
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Nigeria is the only country in Africa which remains endemic of wild poliovirus (wpv) 
transmission. Within Nigeria the northern states constitute the last reservoir of wpv in 
Africa (WHO 2006). Nigeria and India have over the last 6-8 years been the largest 
reservoir of wpv cases globally. During 2003 to 2005 the Global Polio Eradication 
Initiative faced significant challenges in Nigeria, when certain northern states of: Kano, 
Kaduna and Zamfara suspended polio supplementary immunisation activities (SIAs) 
because of concerns regarding vaccine safety. Kano is one of the most highly populated 
states in the north of Nigeria with a population of about 7 million people. Kano 
suspended supplementary immunisation services from April 2003 to July 2004 (CDC 
2005) . 
 
The suspension of immunisation activities had serious consequences, as manifested by 
the sharp increase of wpv cases within in the country from 202 cases in 2002 to 782 
cases in 2004. Apart from the total increase in the number of cases, the number of 
states reporting at least one case of wpv rose from 41% in 2003 to 80% in 2004. There 
was spread of wpv to a number of states within Nigeria which were previously polio free. 
Furthermore, the wild poliovirus resurgence in Nigeria led to the spread of wpv cases to 
18 other countries including three countries outside Africa. The countries which 
experienced importations of wpv from Nigeria had been polio free for 1 year or more. 
 
In the case of the northern states of Nigeria, the communities took the decision not to 
participate in the immunisation activities based on their belief that the polio vaccine was 
not safe. The community decision was taken with apparent support of political leaders 
(governors) of these states, who presented the decision to the federal government. The 
governors of these states again played a significant role in reversing the suspension of 
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immunisation activities as they helped to convince the communities to accept 
immunisation services, thus immunisation activities resumed later in 2004. 
 
This incident of community refusal of immunisation services in Nigeria proved to be a 
major setback for the Global Polio Eradication Initiative; affecting many countries in the 
continent as well as countries outside Africa like Indonesia and Yemen. It left a large 
number of children in Nigeria and in many other countries maimed by the poliovirus 
which originated in Nigeria. Many of those affected may never understand the reasons 
for the suspension of essential health services, but the disability brought on by that 
decision is part of their lives. The fact that they had nothing to do with the decision and 
there was no way they themselves nor their parents could have contributed to the 
decision, changes nothing as they still bear the consequences. It matters not that such 
consequences were not intended by the people of the northern states of Nigeria.  
 
 It is important to point out that when communities refuse to participate in a public health 
intervention programme as it happened in Nigeria, the underlying reason is usually lack 
of trust in authorities; the government and or its partners. Refusal to participate in 
immunisation services in Nigeria is one classical example as it is reported that the 
community had suspicions about the motivation of the public officials and rumoured that 
the vaccine was associated with HIV infection and was contaminated with steroids to 
cause infertility and thus not safe (Pallansch, 2006). Once the issues of trust were 
addressed and negotiations undertaken with the different community leaders the issues 
were clarified, misconceptions addressed and immunisation activities were resumed. 
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Such decisions bring up serious ethical questions as adults take decisions on behalf of 
children. Furthermore, in almost all cases of group decisions there will be those who do 
not share the group concerns and were more worried about the safety and the 
protection of their children from the disease. In such a situation such people normally 
have little alternative as failure to comply with the group decision may almost certainly 
lead to attacks by other members of the community, which may have deadly 
consequences. 
 
Nevertheless, such incidents bring up the important issues of trust and the ethical 
obligation of the health officials to ensure meaningful participation of community 
representatives in decision making on immunisation services and for the programme to 
provide adequate information on the risks associated with the vaccines (Vernon, 2003). 
This will result in an appropriately informed public on service delivery issues, like 
planned activities and will give a sense of ownership for the programme. The refusal of 
communities in Nigeria to participate in immunisation services point to this gap.  
 
It is evident that in such a situation legal enforcement of immunisation services would 
not work, if anything it could make matters worse. Legal enforcement in such a situation 
may bring up resentment by communities and complete breakdown of trust in 
government programmes irrespective of how well intended.  
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7. The Specific Ethical Challenges of EPI-SA 
7.1  Immunisation Policy and the setting  
In South Africa routine immunisation services are offered as part of the essential 
package of Primary Health Care through the Expanded Programme on Immunisation 
(EPI), free of charge in public health facilities. The programme is delivered in line with 
the global strategies and policies of the World Health Organisation (WHO). Based on 
this, the Expanded Programme on Immunisation in South Africa (EPI-SA) implemented 
WHO recommended disease eradication and elimination strategies which include:  
conducting mass immunisation campaigns at 3-4 year intervals, targeted disease 
surveillance and putting efforts into increasing routine coverage. These strategies are 
aimed at eradication and control of vaccine preventable diseases (VPDs) like polio, 
measles and tetanus.  
 
In keeping with the achievements of the immunisation programme in the control of VPDs 
in developed and many developing countries, the EPI –SA has made significant 
achievements in the control of VPDs in the last decade. The incidence of measles has 
dropped from an average of 10 000 to 15 000 cases per year between 1990 and 1997 to 
an average of less than 100  laboratory confirmed measles cases per year between 
2000 and 2006; with 830 laboratory confirmed measles cases per year during the worst 
outbreak. It should however be highlighted that prior to 1998 all clinical cases of 
measles were presumed to be true measles. Since 1998 when case based surveillance 
was instituted, laboratory testing is conducted for all suspected cases, and thus there 
are confirmed and suspected measles cases (Ngcobo 2008).   
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Similarly the incidence of Haemophilus Influenzae type b has been markedly reduced, 
neonatal tetanus has been eliminated and the last case of laboratory confirmed wild 
poliovirus was reported in 1989. Yet between 1980 and 1988 the number of poliomyelitis 
cases in South Africa ranged from 25 to 481; with the highest incidence during polio 
outbreaks of 174 and 481 in 1988 and 1982 respectively (Department of National Health 
and Population Development, South Africa 1990). 
 
Despite the achievements, the immunisation programme faces challenges similar to 
other Primary Health Care Programmes. These challenges include: staff shortages, low 
and poor level of supervision, limited information offered on services provided and other 
constraints. Jackie Smith (2007) reported a national clinic supervision rate of 44% 
(defined as the percentage of clinics and Community Health Centres that had at least 
one supervisory visit per month) for 2006/7. Furthermore, of the 53 districts only 3 had a 
supervision rate of more than 80% (Smith 2007: 31-46). It is in this setting with such 
constraints that immunisation services are offered. This raises other ethical challenges 
which are additional to ethical challenges inherent in the programme. 
The ethical framework which encompasses: utility & beneficence, justice in the form of 
just distribution of burdens and benefits as well as safety, discussed earlier are 
considered at policy development level. Therefore at the level of health care worker and 
patient interaction there are three main ethical areas that apply during an immunisation 
session: confidentiality & privacy, disclosure and informed consent. In medicine the 
respect for autonomy is expressed through informed consent and has come to be 
accepted as a necessary requirement that helps to define an acceptable ethical practice 
in medicine (Paul 2005: 393-406). Parents normally give consent for medical 
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interventions on their children. For consent to be informed and meaningful adequate 
information should be given to a patient, to allow a parent to make an informed decision. 
Information shared should include full disclosure of any risks associated with a proposed 
intervention. However there is lack of agreement as to what constitutes adequate 
disclosure and the amount of information that should be shared with patients. 
It has been argued that in many settings limited information is offered by the 
immunisation services, where offered the risks associated with vaccines are understated 
or minimised. Thus the immunisation programme may be considered coercive, 
misleading and to violate the parental rights to autonomy as in most settings no proper 
effort is directed at obtaining informed consent. Paul raises concerns about the practice 
of informed consent during mass immunisation as part of the Polio Eradication Initiative 
in India (Paul, 2005). He points out that the benefits of polio immunisation are overstated 
whilst risks are understated and brings up the issue of non-disclosure.24  
Developed countries like the United Kingdom and the United States America have a 
written policy on obtaining consent, which is a legal requirement for administering a 
vaccine (National Childhood Vaccine Injury Act cited by Malone 2003: 268; Bradley 
1999: 330-334). Although informed consent for immunisation services is practiced in 
these countries the setting and the constraints faced in developing countries and in 
South Africa make it difficult for the practice of fully informed consent. There is little 
doubt that informed consent has its limitations and when it comes to public health 
                                                 
24 Paul highlights the concerns that parents are not told about the serious risk of developing vaccine 
associated paralytic polio (VAPP) due to the fear of dropping immunisation coverage rates which in turn 
will undermine the objectives of the programme. He points out that the VAPP incidence is much higher in 
India than expected and realised. The high VAPP incidence in India has been reported by others (John 
2004), referred to in the next session on risk of vaccines. 
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programmes this may not be practical. Consequently, others have questioned the 
applicability of informed consent in exercise of public health programmes.  
 
In South Africa, there are two opportunities for providing information on immunisation 
services:  through health promotion talks which are usually offered in the waiting area 
and by the vaccinator when immunisation is administered. The adequacy of the 
information offered during immunisation sessions on the benefits and associated risks of 
immunisation may raise ethical concerns. The health promotion sessions cover a wide 
range of health topics and immunisation is one amongst a number of health topics 
covered. The health promotion sessions are not uniformly provided in all facilities and 
not all facilities have the staff to provide this service. The information given by 
vaccinators generally relates to minor commonly experienced side effects like: mild 
temperature, persistent crying, swelling at injection sites and the date for the next visit. 
The EPI reviews conducted in provinces report that in a number of facilities there is lack 
of uniformity in information given to mothers about side effects and contra-indications 
(Eastern Cape Department of Health, 1998). Reports from two other provinces indicate 
that there is adequate information given to mothers about side effects (KwaZulu Natal 
Department of Health Nov 1998; Northern Province Department of Health May 1998). 
 
It may be safely assumed that the interpretation of what constitutes adequate 
information in these reports did not have the ethical perspective and relates to 
information about common minor side effects and not to rare but serious effects. It is 
certain that the vaccinators hardly if ever refer to the risk of developing encephalitis and 
of developing say vaccine associated poliomyelitis. Whether it is necessary that parents 
should be informed about these very rare side effects in this setting is debatable; thus 
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the focus will be on disclosure of common side effects which may be a cause for 
inconvenience and anxiety to a parent. Using this standard, the parents are in many 
instances not informed of the side effects, thus there is limited disclosure which raises 
concerns on the ethics of this practice.  
 
There is also no written consent form that is filled and signed by parents and care-givers 
before a child is vaccinated during the provision of routine services. It is generally 
assumed that consent is implied by the parent or care-giver bringing the child to a facility 
for immunisation. The same practice applies to the treatment of clients with minor 
ailments. Although it may be argued that due to the fact that immunisation is provided to 
healthy individuals it should be treated more strictly. This may not be a valid argument. 
Nevertheless, adequate information and on the common side effects should be 
provided. The low level of literacy particularly in more remote settings presents a further 
limitation in the options that could be used to inform clients about immunisation.   
 
Similarly with regard to privacy during an immunisation session, the situation differs from 
facility to facility. Whilst in some facilities there is a reasonable level of privacy during 
routine immunisation sessions, in that one client is seen at a time in a consulting room; 
there are a large number of facilities where vaccines are administered in view of other 
users and other facility staff not attending to a particular client.  
 
Immunisation campaigns present a different scenario. Consent forms are filled by the 
parents a couple of weeks or so before a campaign for the children at crèches and pre-
schools.  The children who present to health facilities have no consent forms. The 
teachers at pre-schools distribute the consent forms to parents/care-gives and follow up 
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with them to bring back the consent forms before the dates of an immunisation 
campaign. The information on the form is limited as it mainly informs on the dates of the 
campaign and which vaccines are administered. A statement on the safety and 
effectiveness of the vaccines is included. Common side effects like mild fever and local 
reactions are mentioned. Mention is made to serious side effects that are rare, and 
much rarer than the effects of the disease itself. There is no mention of what exactly 
these serious rare side effects are; parents are encouraged to contact the programme 
should they require additional information (Campaign field guide – NDOH 2007).   
 
With respect to privacy, the campaign setting and services present a much poor picture. 
During immunisation campaigns a large number of children are vaccinated at the same 
time. To ease the work load and work faster, in many facilities children are vaccinated in 
groups of five in a one room or designated section of a bigger hall. In this setting, 
immunisation services are offered in the open, in full view of those who are still waiting 
and passers by.    
 
Issues that may raise concern at the facility level where the health care worker (HCW) 
interacts with the client and the constraints that affect other health services have been 
raised in this section. It may not be practical in this country to provide a kind of service 
during an immunisation session that represent an ideal ethical practice where there is 
full privacy for patients, full disclosure of information and the parents are given an 
opportunity to consent to immunisation even if its not signed but verbal, due to the 
constraints already highlighted.  However, it is possible to address some issues like:  
providing parents and care- givers with more information on the risks and benefits of 
immunisation during health promotion talks and through posters as well as information 
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brochures that can be freely available at the waiting areas. Caution will have to be 
exercised so as not to provide too much information, which may actually cause undue 
fear and anxiety leading to refusal of immunisation services. Such an outcome may 
actually present harm to the children and to the country. It will be necessary to weigh 
and balance the amount of information provided, so it is adequate without information 
overload. To this effect it may be worthwhile to conduct some studies on this area and 
look more closely at the detail of information that should be shared with the public and 
test information provided at different levels of detail. 
 
Effective supervision of PHC services will help improve the general quality of services. 
This will help reduce the risks associated with provision of health services. Currently 
there is no prioritisation of supervision of EPI services. Supervision for immunisation 
services need to be prioritised as these services are offered to healthy individuals and 
tolerance for harm associated with immunisation services is may be much lower than for 
curative services. This point needs to be highlighted with health managers who in turn 
should ensure that prioritisation of immunisation services is addressed.  
 
It is difficult to see how the issue of lack of privacy during campaigns can be adequately 
addressed with the available resources. The nature of the campaigns makes this 
situation inevitable, as for campaigns demand that a large number of children should be 
immunised within a short period of time for campaigns to be effective. This means that 
facilities have to deal with large numbers daily for the whole duration of the campaign. 
However, privacy during routine immunisation should be approached as part of 
continuous improvement efforts by the department of health at all levels: from national, 
provincial, district up to facility level. 
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7.2  Risk in relation to EPI vaccines 
Vaccines offered in the immunisation policy are against: polio, measles, diphtheria, 
tetanus, pertussis, haemophilus influenza type b (Hib), hepatitis B and tuberculosis. 
Vaccines used in the EPI in South Africa meet the international standards set by WHO 
and UNICEF. Furthermore, South Africa has an additional requirement by the Medicines 
Control Council (MCC), in terms of regulation 44 of the Medicines and Related 
Substances Act, Act 101 of 1965, that each batch of vaccines, which already meets the 
WHO requirement, should be tested for safety at the National Control Laboratory (NCL) 
in Bloemfontein before it can be released. Consequently this requirement is considered 
in vaccine logistics and in estimating vaccine delivery.  
 
Notwithstanding the huge benefits of vaccines, vaccines are not absolutely without risk. 
To reduce the risk associated with vaccines, research and development on new 
vaccines and new approaches to immunization is ongoing. Manufacturers continually 
offer newer formulations and vaccine combinations, which are more purified with a lower 
risk profile than earlier products. Furthermore, a risk associated with a particular 
infectious disease changes over time. This necessitates a continual review of the: the 
type of vaccines offered and the risk associated with specific vaccines. These must be 
weighed against the risk of a particular disease at that time.  Therefore, the resultant 
risk-benefit ratio of a specific vaccine is not static.  
 
The use of acellular pertussis and inactivated polio vaccines in many developed 
countries represent the continual shift to the use of vaccines with a lower risk profile. 
Concerns over the safety and reactogenicity of whole cell pertussis vaccines resulted in 
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the development of acellular pertussis, which is less reactogenic but has similar 
protection levels. However, the level of safety for severe adverse reactions for acellular 
and whole cell pertussis appears to be the same (Braun 2000). The USA and many 
European countries including the UK, Sweden, Germany and France now use acellular 
pertussis vaccine. A similar move has been seen with the use of inactivated polio 
vaccine due to concerns over the risk of paralytic poliomyelitis associated with the live 
attenuated oral polio vaccine. Data from WHO indicates that by December 2006 there 
were 42 countries using acellular pertussis and 32 using injectable polio in their national 
immunisation programmes (personal communication & sharing of data with WHO Head 
Quarters through WHO Regional Office, Harare). It is with this background that we focus 
on the vaccine formulations used in EPI – SA and on the risk associated with some of 
vaccines relative to the risk of a particular disease.  
 
The DT (diphtheria and tetanus), measles,  bacillus calmette-guerin (BCG), hepatitis B 
and haemophilus influenzae type b (Hib) vaccines used in the EPI in SA are similar to 
those used in many developed countries; are thus not discussed any further. The 
formulations of pertussis and polio vaccines may be a cause for concern. The EPI in 
South Africa uses whole cell pertussis, not the acellular pertussis used in many 
developed countries which has been used in the USA since 1998. Similarly with polio 
vaccines, SA still uses oral polio vaccine (OPV) which has been associated with a risk of 
developing vaccine associated paralytic polio (VAPP).  
 
The oral polio vaccine (OPV) has been used extensively all over the world as a strategy 
of the global Polio Eradication Initiative. OPV is used in the polio eradication strategy 
particularly during the time of high transmission of wild poliovirus and in countries with 
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persistent transmission of wild poliovirus. The distinct qualities and advantages of OPV 
that made it the vaccine of choice for polio eradication activities include: the ease of 
administration; low price compared to IPV; high efficacy; its ability to spread to un-
immunised contacts causing them to develop immunity against polio and effectively 
blocking wild poliovirus transmission (Kew 2004:16-23). Therefore OPV is much more 
effective in achieving herd immunity particularly in developing countries where 
socioeconomic conditions favour the spread of infections like polio, transmitted through 
the oral – faecal route. 
 
Despite its many advantages, OPV carries the risk of vaccine associated paralytic 
poliomyelitis (VAPP) in the recipient. The occurrence of VAPP varies widely; from 1 case 
per 2,9 million OPV doses in the USA, to 0,4 – 3 per million vaccinated children in 
European countries up to 7 cases per million birth cohort in India. India has one of the 
highest VAPP incidence in the world (Alexander 2004: 1696-1701; John 2004:).   
 
Another complication of OPV is that in countries where OPV coverage is low, the use of 
OPV has been shown to cause paralysis in contacts of recipients due to a circulating 
vaccine derived poliovirus (cVDPV) (Kew 2004). The cVDPV is a result of a vaccine 
derived poliovirus which mutates, becomes virulent and circulates in the community to 
infect those who do not have adequate immunity levels. The mutated virulent virus then 
infects contacts of vaccine recipients and causes paralysis in them, in the same way that 
a vaccine virus (that has not become virulent) can result in protection of contacts. 
Therefore, that where the risk of wild poliovirus infection is low and the economy allows, 
the use of IPV is preferable.  Outbreaks associated with cVDPV have been described in 
Hispaniola in 2000-01, in Philippines in 2001 in Madagascar in 2002 and in Egypt from 
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1983 to 1993 (Kew 2004:16-23). It is for these reasons that many developed countries 
use IPV to eliminate the risk associated with OPV.  
 
In the USA, the last case of wild poliovirus was in 1979.  During the period of 1961 to 
1989, there was an average of 9 VAPP cases per year as a consequence of OPV use. 
Considering this burden of VAPP cases, in 1997 the national vaccination policy was 
changed from total reliance on OPV to a sequential schedule that starts with inactivated 
polio followed by OPV; and by the year 2000 the USA used only IPV in the immunisation 
programme.  The change in policy resulted in an elimination of VAPP when only IPV 
was used (Alexander 2004: 1696-1701). 
 
These issues have significant risk benefit implications for the immunisation programme 
in this country. The last laboratory confirmed wild poliovirus case in this country was in 
1989 (Ngcobo 2008: 9-13). Four (4) national rounds of polio immunisation campaigns 
have been conducted since 1996. In 2006, the Africa Region Certification Commission 
(ARCC) accepted the “National Documentation for the Certification of Poliomyelitis 
Eradication: South Africa” thereby declaring that the country had interrupted wild 
poliovirus transmission (National Certification Committee - South Africa 2006). Although 
the risk for wild poliovirus importations remains, due to ongoing poliovirus transmission 
in some countries in Africa, the justification for a country like South Africa to continue to 
use OPV despite the well documented risks is questionable. Notwithstanding the fact 
that there is no documented case of VAPP in this country, the risk remains. Furthermore 
lack of sensitive specific surveillance for VAPP cases and lack of accurate data may 
explain the absence of documented VAPP cases.  It can be argued that the country has 
enough resources to consider the implementation of inactivated polio (IPV). Considering 
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that Nigeria remains the only country in the Africa region endemic of wild poliovirus 
(WHO 2006), this should be the appropriate time for changing over to injectable polio 
vaccine. The use of IPV in this country becomes more compelling when one considers 
that there is no compensation scheme to provide for the unfortunate ones who may 
develop such adverse effects from immunisation, like VAPP.   
 
A similar argument applies to the use of the whole-cell pertussis vaccine. South Africa 
continues to use whole-cell pertussis in the EPI. However, acellular pertussis vaccine 
use is available and used in the private sector.  Based on the background and the level 
of development this country has reached it is fit that the use whole-cell pertussis and the 
associated risk should be assessed with the view of switching to acellular pertussis. 
Furthermore, one does not want to create or endorse the perception that government 
programmes provide inferior products compared to the private sector. This move may be 
further supported by the proportion of AEFI cases associated with DPT-Hib use which 
are much more than those associated with the other antigens (AEFI data, Nat DOH).  
 
A decision to switch to injectable polio vaccine or acellular pertussis will have cost 
implications. However the incremental cost of changing to safer formulations should be 
weighed against the cost the programme may face should serious AEFI occur. Such 
cost will include damage to the image of the programme and possible court cases which 
may result from litigation. If a serious AEFI occurred with the use of whole-cell pertussis 
vaccine or OPV there could have grave consequences for the image of the programme 
which may cause the public to lose trust in the immunisation programme.  
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There is a definite need to promptly review the risk benefits associated with the use of 
whole cell pertussis and OPV vaccines and seriously consider the use of acellular and 
IPV vaccine. This will help define a proactive risk management approach for a 
programme directed at healthy individuals for public protection. There is a strong moral 
background for the immunisation programme to adopt this approach, which leaves little 
room for litigation and attack by anti-vaccination lobbyists.   
 
Furthermore, risk consideration should extend to other vaccines and ensure some form 
of protection for vaccine recipients who may be unfortunate to suffer vaccine injury. This 
demands establishment of a compensation programme that covers adverse events from 
all the vaccines in the EPI schedule. The moral justification for this is that society will 
share the benefits as well as the risks associated with immunisation. The risk can be 
shared through taxes that can be levied on individuals to fund such a compensation 
programme. Such a compensation programme will ensure a programme that is delivered 
in line with the principle of justice through just distribution of benefits and burdens.   
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7.3 Monitoring of Adverse Events Following Immunisation (AEFI) 
To ensure vaccine safety and monitor programme performance, many immunisation 
programmes around the world monitor the occurrence of adverse events following 
immunisation (AEFI). In South Africa the surveillance for AEFI was implemented in 1997 
(personal communication, EPI – national office). Surveillance for AEFI forms part of 
surveillance for EPI targeted conditions like measles, acute flaccid paralysis (AFP) and 
neonatal tetanus. This surveillance is conducted by the EPI unit, separate from that 
conducted by the Medicines Control Council (MCC) through the National Adverse Drug 
Event Monitoring Centre (NDEMC) in Cape Town. The National Adverse Drug Event 
Monitoring Centre forms part of the National Pharmacovigilance Programme conducting 
post marketing surveillance. Information is shared between these two programmes i.e. 
NDEMC and EPI. 
 
Training on immunisation conducted by the national and provincial offices normally 
includes AEFI. Surveillance forms are generally available in all health facilities around 
the country. Investigations are conducted on all serious cases, which include all cases 
admitted to hospital and deaths presumed to be associated with immunisation. Staff 
from the district and provincial offices conducts the investigation. The national office is 
involved in the investigation of all cases that involve death and other serious cases, like 
where a post mortem is needed and cases which involve the media. Determining 
causality is a challenge, as a number of cases particularly deaths may be attributed to 
immunisation when immunisation is not the cause. This is similar to experiences of other 
AEFI monitoring systems. The high prevalence of HIV/AIDS in this country is another 
compounding factor, due to number of children already sick from HIV who may die within 
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a few days after immunisation due to an HIV related illness. In such cases, the fact that 
the child was recently immunised is merely coincidental. However, health workers and 
particularly the parents often find it difficult to separate the two and often assume that 
immunisation is the cause of death (NDOH, AEFI Surveillance data, National 2003-
2006, unpublished).  
 
There is no standing committee at national office that reviews and classifies AEFI cases. 
A committee that was functional in 2000 in response to a court case of a child presumed 
to have died from DPT-Hib immunisation, stopped functioning when the case was 
closed. It is reported that KwaZuluNatal province has a standing committee that reviews 
and classifies all AEFI cases from this province. There is no indication of any other 
province with a similar committee (personal communication EPI-SA national office and 
with KwaZuluNatal EPI Manager). This means that, at national level the programme has 
no proper system of reviewing the quality of surveillance and classification of AEFI 
cases. This is of particular concern for serious cases perceived to be associated with 
immunisation.  
 
Data from the NDOH EPI indicates that the rate of AEFI in the last 3 to 4 years range 
from 50 to 90 cases a year. DPT-Hib vaccine is associated with the highest number of 
AEFI compared to other vaccines followed by BCG. All reported deaths presumed to be 
associated and fully investigated, have been found to be coincidental (unpublished data, 
AEFI surveillance 2003-2006, NDOH). The sensitivity and quality of the surveillance for 
AEFI is an area that has not been studied. There may be concerns regarding the 
sensitivity of reporting and level of health worker awareness on reporting AEFI.  It is 
expected that the number of AEFI cases should be roughly proportional to the number of 
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vaccine doses administered. This means that all things equal, provinces with a large 
target population and thus administer a large number of vaccine doses will be expected 
to have more cases of AEFI compared to provinces with a smaller target population.  
This is not the case, as it is not reflected in the AEFI surveillance data. AEFI cases 
generally originate from a few provinces like KZN, Mpumalanga and Western Cape that 
have higher levels of reporting with other provinces having much fewer cases or being 
quiet. (AEFI surveillance 2003-2006 NDOH, unpublished) 
 
Based on the data and information from the NDOH it appears that the AEFI monitoring 
system needs to be strengthened. This should include ongoing training and sensitisation 
of health workers, ensuring full investigation of cases with visits of the affected families. 
Considering that in countries like the USA, surveillance of AEFI is mandated by 
legislation, this places a compelling need for this country to set up a Committee of 
experts to review serious AEFI cases. Such a committee could consist of: paediatricians, 
neurologists, epidemiologists, public health specialists and medico–legal experts to 
assess all serious AEFI cases, properly classify cases, continually appraise the AEFI 
monitoring system and recommend appropriate compensation for serious adverse 
events when such a system is in place.   
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8.  Recommendations and Conclusion  
 
Recommendations  
Although this study was on ethical aspects some issues raise legal aspects, therefore 
the recommendations have a bearing on policy and legislation. The primary objective of 
the recommendations is to position the immunisation programme in South Africa such 
that despite the constraints faced, it is responsive to ethical concerns related to the 
programme. The aim is an immunisation programme that is proactive in addressing risk 
issues through a system that will avoid litigation. In order to achieve this, the following 
recommendations are made.  
 
Policy Review 
The Director: Child and Youth Health, overseeing the EPI programme at the National 
Department of Health should revise the EPI policy to address the following 
recommendations: 
i) Policy should be reviewed to ensure that supervision for EPI services is 
prioritised. Health Managers at all levels should be alerted to this need.  
ii) All health facilities offering immunisation services should provide adequate 
information on immunisation to parents and care givers. The information should 
cover the benefits and the risks associated with immunisation. Where literacy 
levels are low, structured and regular health promotion talks before immunisation 
sessions should be conducted. 
iii) The decision making process on rendering the immunisation services should 
ensure meaningful involvement of appropriate community members at all levels 
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from national, to province, district, municipality right up to facility level. The 
immunisation policy should reflect this.  
iv) The immunisation policy should require a continual assessment by experts at 
determined intervals of risk–benefit issues of certain vaccine antigens and 
vaccine preventable diseases. The assessment of risk posed by OPV and whole-
cell pertussis vaccines is now due.  
v) The surveillance system and management of Adverse Events Following 
Immunisation (AEFI) should be strengthened with ongoing training and 
sensitisation sessions for health workers to ensure a high level of sensitivity and 
an effective response to serious incidents.   
 
Legislation  Review 
The Director General: Health, should establish a comprehensive piece of legislation that 
will deal with immunisation services, which will address the following areas: 
i) A Compensation System for those who suffer serious adverse events 
following immunisation should be established to ensure a well structured 
compensation process to address this risk. Legislation should mandate the 
development of Compensation System and a Compensation Fund for the 
proposed system.  
ii) Surveillance of AEFI should be mandated by law. An AEFI should therefore be 
a notifiable medical condition and should be included in the list of medical 
conditions under the National Health Act 2003 (Act NO. 61 of 2003).   
iii) The proposed legislation should provide for formation of an independent AEFI 
Committee of experts will regularly review all serious cases of adverse events 
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following immunisation (AEFI), classify them and identify those eligible for 
compensation.  
iv) Continual review and assessment of risk benefit ratios for different conditions 
covered by EPI at intervals of 5 years should be required by law. An efficient 
AEFI surveillance system will provide crucial information required for this 
exercise. 
 
Conclusion  
Universal immunisation is ethically defensible based on the various ethical theories and 
principles. South Africa’s experience with the measles outbreak in 2003 to 2005 does 
not only demonstrate the compelling need to continue with the provision of universal  
immunisation services and maintain high coverage levels; it points to the existence of a 
social contract. Therefore, there is no moral basis for individuals to refuse to have their 
children vaccinated except when it is medically contraindicated. However, there remains 
room for improvement of ethical practices at service delivery. The risk–benefit elements 
for each vaccine and the profile of targeted diseases are continually changing. Thus, 
there is a need for ongoing assessment of risk benefit issues to ensure the use of 
appropriate vaccines with optimal safety. The recommendations aim for an immunisation 
programme of an acceptable ethical standard and that addresses the main risk issues 
associated with immunisation by establishing a legislated compensation system.  
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